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Abstract
My thesis work is centered around the development of R software packages
for analyzing RNA sequencing (RNA-seq) and ChIP sequencing (ChIP-seq)
high throughput genomic data. Chapter 2 describes the derfinder Biocon-
ductor package which implements the DER Finder approach for identifying
differentially expressed regions with RNA-seq data in an annotation-agnostic
manner. Chapter 3 shows how derfinder can be applied to ChIP-seq data to
identify differentially bounded regions. Chapter 4 describes the regionReport
Bioconductor package for producing HTML or PDF reports from region-based
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This thesis work is part of a larger collective effort to address the public
health problem presented by neuropsychiatric disorders. This thesis work will
lead to improving our understanding of the genomic data and will generate
hypothesis, which will then be further analyzed by the team of scientists at
the Lieber Institute for Brain Development as well as other institutions. This
work is part of the team effort to improve the health and quality of life of
individuals with neuropsychiatric disorders.
The goal of this thesis work is to develop statistical methods and software
that enable researchers to differentiate the sources of variation observed in
RNA-seq while minimizing the dependance on known annotation. This will
allow researchers to correct for technological variation and study the biological
variation driving their phenotype of interest. Then apply these methods to
further our understanding of neuropsychiatric disorders using the Lieber
Institute for Brain Development human brains collection (> 1000 samples).
To accomplish this goal, this thesis work was jointly supervised by Jeffrey
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T. Leek from the Johns Hopkins Bloomberg School of Public Health Depart-
ment of Biostatistics and Andrew E. Jaffe from the Lieber Institute for Brain
Development. This work resulted in several R packages which are all part
of the Bioconductor project [1], which means that the software is very well
documented, regularly tested, and easy to install by R users.
1.1 derfinder applied to RNA-seq data
Differential expression analysis of RNA sequencing (RNA-seq) data typically
relies on reconstructing transcripts or counting reads that overlap known gene
structures. In under to better understand the human brain, transcriptome anal-
ysis provides fundamental insight into development and disease. However,
this type of analysis typically relies on the existing annotation which might
not be complete in some situations, particularly for less studied organisms.
As a complement to typical transcriptome analysis pipelines, the DER
Finder statistical approach seeks to identify contiguous regions of the genome
showing differential expression signal at single base-pair resolution [2]. DER
Finder does not rely on existing annotation or potentially incomplete tran-
scriptome, thus allowing researchers to further study tissues like the human
brain. Chapter 2 describes the derfinder R package that implements the DER
Finder approach [3] with visualizations created with the derfinderPlot [4]
package. We used it with data generated by the Lieber Institute for Brain
Development and determined that the human brain transcriptome annotation
is incomplete [5].
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1.2 derfinder applied to ChIP-seq data
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) exper-
iments identify regions of the genome with binding signal for a protein of
interest. When multiple samples are collected for different conditions, treat-
ments or other covariates, researchers will ask if there is differential binding
between these conditions. The current strategies for answering this question
rely on merging peaks from the different samples which can lead to un-wanted
issues. These strategies do not take into account the variability across samples
when merging peaks. Chapter 3 shows how derfinder can be used with
ChIP-seq data to identify differentially bound regions. We illustrate this ap-
plication using data from the EpiMap study [6] for histone marks H3K4me3
and H3K27ac from the anterior cingulate cortex and dorsolateral prefrontal
complex of the human brain.
1.3 Interactive region based reports with
regionReport
Many analyses of genomic data result in regions along the genome that as-
sociate with a covariate of interest. These genomic regions can result from
identifying differentially bound peaks from ChIP-seq data, identifying differ-
entially methylated regions (DMRs) from DNA methylation data, derfinder
analyses, among other analysis pipelines. The genomic regions themselves are
commonly stored in a GRanges object from GenomicRanges [7] and have some
common properties such as p-values associated with each region. Chapter
3
4 describes the regionReport [8] R package for creating interactive HTML
reports for region-based genomic analyses. These reports are useful for ex-
ploring results and can be shared with collaborators. regionReport can also
be used to explore DESeq2 [9] and edgeR-robust [10] results, which are among
the most widely used differential expression software packages.
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2.1 Abstract
Background Differential expression analysis of RNA sequencing (RNA-seq)
data typically relies on reconstructing transcripts or counting reads that over-
lap known gene structures. We previously introduced an intermediate statis-
tical approach called differentially expressed region (DER) finder that seeks
to identify contiguous regions of the genome showing differential expres-
sion signal at single base resolution without relying on existing annotation or
potentially inaccurate transcript assembly.
Results
We present the derfinder software that improves our annotation-agnostic
approach to RNA-seq analysis by: (1) implementing a computationally effi-
cient bump-hunting approach to identify DERs which permits genome-scale
analyses in a large number of samples, (2) introducing a flexible statistical
modeling framework, including multi-group and time-course analyses and (3)
introducing a new set of data visualizations for expressed region analysis. We
apply this approach to public RNA-seq data from the Genotype-Tissue Expres-
sion (GTEx) project and BrainSpan project to show that derfinder permits the
analysis of hundreds of samples at base resolution in R, identifies expression
outside of known gene boundaries and can be used to visualize expressed
regions at base-resolution. In simulations our base resolution approaches
enable discovery in the presence of incomplete annotation and is nearly as
powerful as feature-level methods when the annotation is complete.
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Conclusions derfinder analysis using expressed region-level and sin-
gle base-level approaches provides a compromise between full transcript
reconstruction and feature-level analysis. The package is available from
Bioconductor at www.bioconductor.org/packages/derfinder.
Keywords RNA sequencing, differential expression analysis, coverage,
gene annotation, gene expression.
2.2 Introduction
The increased flexibility of RNA sequencing (RNA-seq) has made it possible
to characterize the transcriptomes of a diverse range of experimental systems,
including human tissues [1, 2, 3], cell lines [4, 5] and model organisms [6, 7].
The goal of many experiments involves identifying differential expression
with respect to disease, development, or treatment. In experiments using
RNA-seq, RNA is sequenced to generate short “reads” (36-200+ base pairs).
These reads are aligned to a reference genome, and this alignment information
is used to quantify the transcriptional activity of both annotated (present in
databases like Ensembl) and novel transcripts and genes.
The ability to quantitatively measure expression levels in regions not pre-
viously annotated in gene databases, particularly in tissues or cell types that
are difficult to ascertain, is one key advantage of RNA-seq over hybridization-
based assays like microarray technologies. As complicated transcript struc-
tures are difficult to completely characterize using short read sequencing
technologies [8], the most mature statistical methods used for RNA-seq analy-
sis rely on existing annotation for defining regions of interest - such as genes
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or exons - and counting reads that overlap those regions [9]. These counts are
then used as measures of gene expression abundance for downstream differ-
ential expression analysis [10, 11, 12, 13, 14, 15, 16, 17, 18]. Unfortunately, the
gene annotation may be incorrect or incomplete, which can affect downstream
modeling of the number of reads that cross these defined features.
We previously proposed an alternative statistical model for finding dif-
ferentially expressed regions (DERs) that first identifies regions that show
differential expression signal and then annotates these regions using previ-
ously annotated genomic features [19]. This analysis framework first proposed
using coverage tracks (i.e. the number of reads aligned to each base in the
genome) to identify differential expression signal at each individual base and
merges adjacent bases with similar signal into candidate regions. However,
the software for our first version was limited to small sample sizes, the abil-
ity to interrogate targeted genomic loci, and comparisons between only two
groups.
Here we expand the DER finder framework to permit the analysis of
larger sample sizes with more flexible statistical models across the genome.
This paper introduces a comprehensive software package called derfinder
built upon base-resolution analysis, which performs coverage calculation,
preprocessing, statistical modeling, region annotation and data visualization.
This software permits differential expression analysis at both the single base
level, resulting in direct calculation of DERs [20], and a feature summarization
we introduce here call "expressed region" (ER)-level analysis. We show that ER
analysis allows us to perform base resolution analysis on larger scale RNA-seq
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data sets using the BrainSpan project [21] http://developinghumanbrain.org
and Genotype-Tissue Expression (GTEx) project data [3] to demonstrate that
derfinder can identify differential expression signal in regions outside of
known annotation without assembly. We use these DERs to illustrate the
post-discovery annotation capabilities of derfinder and label each DER as
exonic, intronic, intergenic or some combination of those labels. We show
that some of these DERs we identify are outside of annotated protein coding
regions and would not have been identified using gene or exon counting
approaches.
In the GTEx data, we identify differentially expressed regions (DERs) that
differentiate heart (left ventricle), testis and liver tissues for 8 subjects. There
are many potential reasons for this observed intronic expression including
intron retention, background levels of mis-transcription, or incomplete protein-
coding annotation. A subset of these strictly intronic ERs are associated with
tissue differences, even conditional on the expression of the nearest annotated
protein-coding region. However, we point out that intronic expression may be
artifactual and it our package permits visualization and discovery of potential
expression artifacts not possible with other packages.
Finally, using simulated differentially expressed transcripts, we demon-
strate that when transcript annotation is correct, derfinder is nearly as power-
ful as exon-count based approaches with statistical tests performed by limma
[16] (or DESeq2 [14], edgeR-robust [13]) and ballgown [22] after summarizing
the information using Rsubread [13] and StringTie [23] respectively. Finally,
we also demonstrate that when annotation is incomplete, derfinder can be
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substantially more powerful than methods that rely on a complete annotation.
2.3 Materials & Methods
2.3.1 Overview of R Implementation
We chose to implement derfinder entirely in the R statistical environment
www.R-project.org/. Our software includes upstream pre-processing of BAM
and/or BigWig files into base-resolution coverage. At this stage the user can
choose to summarize the base resolution coverage into feature-level counts
and apply popular feature-level RNA-seq differential expression analysis tools
like DESeq2 [14], edgeR-robust [13], limma [16, 15] and voom [17].
derfinder can be used to identify regions of differential expression ag-
nostic to existing annotation (Figure 4.1). This can be done with either the
expressed regions (ER)-level or single base-level approaches, described in
detail in the following subsection and Supplementary Section 2.12.1. The
resulting regions can then be visualized to identify novel regions and filter
out potential artifacts.
After differential expression analysis, derfinder can plot DERs using base-
resolution coverage data by accessing the raw reads within differentially
expressed regions for posthoc analysis like clustering and sensitivity analyses.
We have also created a lightweight annotation function for quickly annotat-
ing DERs based on existing transcriptome annotation, including the UCSC
knownGene hg19, Ensembl p12, and Gencode v19 databases as well as newer
versions.
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Vignettes with detailed instructions and examples are available through the
Bioconductor pages for derfinder and derfinderPlot. The main functions for
the expressed region and single base-level approaches are further described
in Supplementary Section 2.11.1.
2.3.2 Expressed region level analysis
In the expressed region approach, we compute the mean coverage for all base
pairs from all the samples and filter out those below a user specified cutoff.
Contiguous bases passing this filtering step are then considered a candidate
region (Figure 2.2A). Then for each sample, we sum the base-level coverage
for each such region in order to create an expression matrix with one row
per region and one column per sample. This matrix can then be used with
feature-level RNA-seq differential expression analysis tools.
2.3.3 Annotation and “Genomic State” Objects
We have implemented a “genomic state” framework to efficiently annotate
and summarize resulting regions, which assigns each base in the genome
to exactly one state: exonic, intronic, or intergenic, based on any existing or
user-defined annotation (e.g. UCSC, Ensembl, Gencode). At each base, we
prioritize exon > intron > unannotated across all annotated transcripts.
Overlapping exons of different lengths belonging to different transcripts
are reduced into a single “exonic” region, while retaining merged transcript
annotations. We have a second implementation that further defines promot-
ers and divides exonic regions into coding and untranslated regions (UTRs)
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which may be useful for the user to more specifically annotate regions - this
implementation prioritizes coding exon > UTR > promoter > intron > unan-
notated.
2.3.4 Data Processing for Results in Main Manuscript
2.3.4.1 BrainSpan data
BigWig files for all 487 samples across 16 brain regions were downloaded
from the BrainSpan website [21]. The samples for HSB169.A1C, HSB168.V1C
and HSB168.DFC were dropped due to quality issues. Based on exploratory
analyses the coverage was assumed to be reads-per-million mapped reads in
this data set. We set the coverage filter to 0.25 for both the single base-level
and ER-level derfinder approaches. Since the coverage is already adjusted to
reads per million mapped reads we did not include a library size adjustment
term in the single base-level derfinder analysis (see Supplementary Section
2.12.1 for details on this adjustment term). The details for the single base-level
derfinder analysis are described further in Supplementary Section 2.12.2. For
the ER-level approach we only considered regions longer than 5 base-pairs.
We sought to identify differences in expression across brain region (neocor-
tical regions: DFC, VFC, MFC, OFC, M1C, S1C, IPC, A1C, STC, ITC, V1C and
non-neocortical regions: HIP, AMY, STR, MD, and CBC) and developmental
stage (fetal versus postnatal). We therefore fit the following region-by-stage
interaction alternative model, which included main effects for fetal versus
postnatal (binary) and categorical brain region variable (15 region indicators,
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relative to A1C), and interaction terms for each brain region and developmen-
tal stage. This resulted in a total of 32 terms in the model (intercept; 16 main ef-
fects, 15 interaction terms). In equation (2.1), yij is the scaled log2 coverage for
the expressed region i and sample j. That is, yij = log2
(
mean coverageij + 1
)
.
The model is completed by an intercept term αi, a indicator variable for fetal
status βi, m indicators variables γ for the brain region, and m interaction vari-
ables ζ between fetal status and brain region. The term ϵij represents residual
error.








ζiqFetalj ∗ Regionjq + ϵij (2.1)
We compared the above model to an intercept-only model using the lmFit
function from limma [16, 15]. The p-values for the ER-level DERs were adjusted
via the Bonferroni method and those with adjusted p-values less than 0.05
were determined to be significant. We then calculated the mean coverage for
each significant expressed region DERs in each sample, resulting in a mean
coverage matrix (DERs by samples), and we performed principal component
analysis (PCA) on this log2-transformed matrix (after adding an offset of 1).
Once the DERs were identified, we identified which of them overlap EN-
CODE blacklisted regions of the genome [4] using the file at
hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeMapability/
wgEncodeDacMapabilityConsensusExcludable.bed.gz. For identifying which
DERs overlap lincRNAs we used EnsDb.Hsapiens.v75 [24], which can also be
used for a variety of transcript types. We then performed the gene ontology
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analysis for the DERs using GOstats [25] using as background all genes that
are within 5 kb of an ER.
2.3.4.2 GTEx data
We selected samples from individuals that had data from heart (left ventricle),
liver and testis tissues with RIN values greater than 7. 8 subjects matched
this criteria and we selected only 1 sample if their tissue was analyzed more
than once, leaving us with 24 samples. The data was aligned using Rail-RNA
[26] version 0.2.1 with the code as described at github.com/nellore/runs. We
created a normalized mean BigWig file for these 4 samples adjusted for library
sizes of 40 million reads. We then identified the ERs using a cutoff of 5 using
the function railMatrix from derfinder version 1.5.19.
For each expressed region greater than 9bp, we assigned its annotation
status by using a genomic state object created with the Ensembl GRCh38.p5
database. We then performed principal component analysis (PCA) on the
log2-transformed matrix (after adding an offset of 1) separately for strictly
exonic and strictly intronic ERs. Using limma [16, 15] functions lmFit, ebayes
we fit an intercept-only null model and an alternative model with coefficients
for tissue differences. For each ER we calculated a F-statistic and determined
whether it was differentially expressed by tissue using a Bonferroni adjusted
p-value cutoff of 0.05.
For the conditional expression analysis, we found the nearest exonic ER for
each intronic ER using the distanceToNearest function from GenomicRanges
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[27]. For each intronic ER we fitted two linear regression models for the log2-
transformed coverage matrix (after adding an offset of 1). For the alternative
model we used as covariates two tissue indicator variables (Heart as the
reference) and the coverage from the nearest stricly exonic ER as shown in
Equation (2.2) for ER i and sample j. For the null model we only used the
coverage from the nearest exonic ER. We calculated an F-statistic using the
anova function that tests whether β1i or β2i are equal to 0 and used a Bonferroni
adjusted p-value cutoff of 0.05 to identify which intronic ERs had differential
expression adjusting for the coverage at the nearest exonic ER.
yij = αi + β1iTestisj + β2iLiverj + γiExonicCoveragej + ϵij (2.2)
2.3.4.3 Simulated data
We simulated 100 bp paired-end reads (250bp fragments, sd = 25) with
polyester [28] for two groups with five samples per group from human
chromosome 17 with uniform error rate of 0.005 and replicated this process
three times. One sixth of the transcripts were set to have higher expression
(2x) in group 2, a sixth to have lower expression in group 2 (1/2x) and the re-
maining two thirds to be equally expressed in both groups. Given a RNA-seq
experiment with 40 million paired-end reads, assuming that all transcripts
are equally expressed we would expect 1,989,247 of them to be from chro-
mosome 17 based on the length of all exons using the known transcripts
UCSC knownGene hg19 annotation. We used this information and the tran-
script length to assign the number of reads per transcript in chromosome
17
17 and generated the number of reads with the NB function from polyester
with mean µ and size (see stats::rnbinom function in R) equal to 13 µ. This
resulted in an average of 2,073,682 paired-end reads per sample. For each
simulation replicate, paired-end reads were aligned to to the hg19 reference
genome using HISAT version 0.1.6-beta [29] and Rail-RNA version 0.2.2b [26].
We created a GTF file using all known transcripts from chromosome 17 as well
as one with 20% of the transcripts missing (8.28% of exons missing). Using
these two GTF files we performed transcript quantification with StringTie
version 1.2.1 [23] as well as exon counting allowing multiple overlaps with the
featureCounts function from Rsubread version 1.21.4 [13]. ERs were deter-
mined with derfinder version 1.5.19 functions regionMatrix and railMatrix
respectively from the HISAT BAM and Rail-RNA BigWig output using a mean
cutoff of 5 for libraries adjusted to 80 million single-end reads. Count matrices
resulting from featureCounts and derfinder were analyzed with limma [16],
DESeq2 [14] and edgeR-robust [18] controlling the FDR at 5% and testing for dif-
ferences between the two groups of samples. We used ballgown version 2.2.0
[22] to perform differential expression tests using coverage at the transcript
and exon levels, controlling the FDR at 5%.
The 3900 transcripts from chromosome 17 are composed in total by 39,338
exons (15,033 unique). To avoid ambiguous truth assignments, we used only
the 3,868 that overlap only 1 transcript and assigned the truth status based
on whether that transcript was set to have a high or low expression on group
2 for the replication replicate under evaluation. We assessed the different
pipelines by checking if these 3,868 exons overlapped at least one differentially
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expressed unit: exons (featureCounts and ballgown), transcripts (ballgown),
and ERs (derfinder) respectively. We then calculated the empirical power,
false discovery rate and false positive rate.
2.4 Results
2.4.1 Overview of the derfinder package
The derfinder package includes functions for several stages in the analysis of
data from an RNA-sequencing experiment (Figure 4.1).
First, derfinder includes functions for pre-processing coverage data from
BAM files or bigWig coverage files. The base-level coverage data for multiple
samples can be loaded and filtered since most bases will show zero or very
low coverage across most samples. Then, the software allows for definition
of contiguous regions that show average coverage levels above a certain
threshold. These expressed regions are non-overlapping subsets of the genome
that can then be counted to arrive at a matrix with an expression value for
each region in each sample. Alternatively, the software provides options for
counting exons or genes for use in more standard analysis pipelines.
Next, derfinder can be used to perform statistical tests on the region level
expression matrix. These tests can be carried out using any standard package
for differential expression of RNA-seq data including edgeR [10, 12], DESeq
[11], DESeq2 [14], or limma-voom [17].
derfinder can then be used to annotate the differentially expressed regions
(DERs). We have developed functions that label each region according to
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Figure 2.1: An overview of the derfinder suite The derfinder software package
includes functions for processing and normalizing coverage per sample, performing
statistical tests to identify differentially expressed regions, labeling those regions with
known annotation, and visualizing the results across groups.
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whether it falls entirely in a previously annotated protein coding exon (exonic),
entirely inside a previously annotated intronic region (intronic), or outside of
any previously annotated gene (intragenic). The software also will report any
region that overlaps any combination of those types of regions.
Finally, data from an expressed region analysis can be visualized using
different visualization approaches. While region-level summaries can be plot-
ted versus known phenotypes, derfinder also provides functions to plot base
resolution coverage tracks for multiple samples, labeled with color according
to phenotype.
We now provide more detail on each of these steps.
2.4.2 Finding expressed regions
The first step in a derfinder analysis is to identify expressed regions. Reads
should be aligned using any splicing aware alignment tool such as TopHat2
[30], HISAT [29] or Rail-RNA [26].
Base resolution coverage information can be read directly from the BAM
files that are produced by most alignment software [30, 29, 26]. This process
can be parallelized across multiple cores to reduce computational time. An
alternative is to read bigWig [31] coverage files. Recent alignment software
such as Rail-RNA [26] produces these files directly, or they can be created using
samtools [32] or produced using the derfinder package. Reading bigWig files
can produce significant computational and memory advantages over reading
from BAM files.
The coverage information represents the number of reads that covers each
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genomic base in each sample. derfinder first filters out bases that show low
levels of expression across all samples. Since most genomic bases are not
expressed, this filtering step can reduce the number of bases that must be
analyzed by up to 90%, reducing both CPU and memory usage. We originally
proposed performing a statistical test for every base in the genome [19] and
this approach is still supported by the derfinder package for backwards
compatibility (Supplementary Section 2.11.3).
Figure 2.2: Finding regions via expressed region-level approach on chromosome 5
with BrainSpan data set. A Mean coverage with segments passing the mean cutoff
(0.25) marked as regions. B Raw coverage curves superimposed with the candidate
regions. Coverage curves are colored by brain region and developmental stage (NCX:
Neocortex: Non-NCX: Non-neocortex, CBC: cerebellum, F: fetal, P: postnatal). C
Known exons (dark blue) and introns (light blue) by strand for genes and subsequent
transcripts in the locus. The DERs best support the GABRA6 transcript with a red star,
indicating the presence of a differentially expressed transcript.
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Here we focus on a new approach based on the bump-hunting method-
ology for region level genomic analysis [33] (Figure 2.2). This approach first
calculates expressed regions (ERs) across the set of observed samples. For
each base, the average, potentially library size-adjusted, coverage is calculated
across all samples in the data set. This generates a vector of (normalized) mean
level expression measurements across the genome. Then an average-coverage
cutoff is applied to this mean coverage vector to identify bases that show
minimum levels of expression. An expressed region is any contiguous set of
bases that has expression above the mean expression cutoff.
The next step is to count the number of reads (including fractions of reads)
that overlap each expressed region. As we have pointed out previously [19]
that counting expression in genes and exons is complicated by overlapping
annotation. Expressed regions are non-overlapping, so this means that each
read can be unambiguously assigned to the appropriate region.
2.4.3 Expressed region level statistical tests
The result of the expressed region (ER) step is a coverage matrix with each
row corresponding to one ER and each column corresponding to one sample.
This count matrix can then be analyzed using statistical models that have been
developed for gene or exon counts such as limma [16, 15], voom [17], edgeR-
robust [18], and DESeq2 [14]. We emphasize that unlike other feature-level
counting approaches, our approach is annotation-agnostic: ERs are defined
empirically using the observed sample data and coverage threshold. So if
there is sufficient expression in a region outside of previously annotated genes
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it will be quantified and analyzed with our approach.
2.4.4 Visualizing differentially expressed regions
After statistical modeling, derfinder produces a set of DERs with summary
statistics per region. They are stored as a GRanges object [27] and can be
visualized with a range of packages from the Bioconductor suite. We have
also developed several visualization tools specific to the derfinder approach.
These plots can be made at different levels of summarization. First, the
derfinder and derfinderPlot packages provide a range of visualizations of
coverage tracks at single base resolution. These plots can be used to identify
coverage patterns that may diverge from annotated protein-coding regions.
For example, using the GTEx example we can visualize genes that have
consistently high intronic expression as shown in Figure 2.3. We show several
examples of genes known to be functionally important in heart - LBD3 and
MYOZ2 (Figure 2.3A,B) [34, 35], and liver - HGD and UPB1 (Figure 2.3C,D) [36,
37]. The coverage profiles can provide additional insight into transcription,
and well as potential technical artifacts, beyond the level of annotated genes,
exons and transcripts, which we include in our base-resolution plots.
DERs can be grouped into larger regions by distance, which can be useful
to identify potentially systematic artifacts such as coverage dips (Figure 2.4),
perhaps due to sequence composition. Visualizing the base-level coverage
for a set of nearby candidate DERs can reveal patterns that explain why one
DER is sometimes fragmented into two or more shorter DERs. Coverage dips
(Figure 2.4), spikes and data quality in general can affect the borders of the
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Figure 2.3: Coverage plots for the average coverage levels for the GTEx example.
Average coverage profile for heart (blue), liver (red), and testis (green) from the GTEx
example near genes: A LDB3, B MYOZ2, C HGD, and D UPB1.
candidate DERs. Some artifacts can be discarded, like candidate DERs inside
repetitive regions. Base-pairs inside repetitive regions available in repeat
masker tracks can be flagged and filtered out from the analysis. Other known
potentially problematic regions of the genome, like those with extreme GC
content or mappability issues can also be filtered out, either before identifying






















Figure 2.4: Example of a coverage dip. Mean coverage per group for the BrainSpan
data set for a region that results in two DERs for a single exon due to a coverage dip.
The genome segment shown corresponds to the DERs cluster ranked 15th in terms of
overall signal by the single base-level approach applied to the BrainSpan data set.
2.4.5 Annotating differentially expressed regions
The DERs can be annotated to their nearest gene or known feature using
bumphunter [33]. The basic approach is to overlap DERs genomic coordi-
nates with the genomic coordinates of known genomic features. By default,
derfinder labels each identified region as exonic, intronic, intragenic or some
combination of those three labels.
A region may overlap multiple genomic features (say an exon and the
adjacent intron). Using this information candidate DERs can further be com-
pared to known gene annotation tables (Methods Section 2.3.3) to identify
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potentially novel transcription events. Using this information, visualizations
of specific loci for overlap with annotation can be made with derfinderPlot.
The regions can be exported to CSV files or other file formats for followup
and downstream analyses. We have also developed a complementary R
package for creating reproducible reports incorporating the annotation and
visualization steps of the derfinder pipeline called regionReport [38].
2.4.6 Application: large-scale expression analysis at base res-
olution
We used derfinder to detect regions that were differentially expressed across
the lifespan in the human brain. We applied derfinder to the BrainSpan
RNA-seq coverage data (Methods Section 2.3.4.1), a publicly available data set
consisting of 484 postmortem samples across 16 brain regions from 40 unique
individuals that collectively span the full course of human brain development
[21]. We used the expressed region approach described above for this analysis.
For comparison we applied the single-based resolution approach previously
utilized on independent dorsolateral prefrontal cortex RNA-seq data [20]
(Supplementary Section 2.11.4).
We identified 174,610 ERs across the 484 samples with mean across-sample
normalized coverage > 0.25, which constituted 34.57 megabases of expressed
sequence. The majority (81.7%) of these ERs were labeled as strictly exonic
while only a small subset (5.4%) were strictly non-exonic by Ensembl annota-
tion. These ERs largely distinguished the fetal and postnatal samples using
PCA - the first principal component explained 40.6% of the variance of the
mean coverage levels and separated these developmental stages across all
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brain regions. This separation was consistent regardless of the annotation
status of the DERs including in the strictly intronic regions (Figure 2.5 and
Supplementary Figure 2.9). The separation between brain regions in intronic
regions may be due to noisy or incorrect splicing [39] or may be due to missing
annotation [19] or mistaken sequencing of pre-mRNA. The base resolution
visualizations available as part of derfinder and derfinderPlot make it pos-
sible to explore to determine if it is biology or artifacts driving these expression
differences.
The PCA plots also appear to show patterns consistent with potential
artifacts such as batch effects [40] ( Figure 2.5). Regardless, the new ER
approach we present here provides options for analysts who wish to discover
patterns of expression outside of known annotation on hundreds of samples -
an analysis of this scope and scale was unfeasible with earlier versions of our
single base resolution software [19].
Using statistical models where expression levels were associated with
developmental stage (fetal versus postnatal) and/or brain region (Methods
Section 2.3.4.1), we found that 129,278 ERs (74%) were differentially expressed
by brain region and/or developmental stage at the ER-level controlling the
family-wise error rate (FWER) at < 5% via Bonferroni correction. We con-
trolled the FWER instead of the FDR due to the expected large effects between
the developmental stages and/or brain regions. The 129,278 ER-level DERs
overlapped a total of 17,525 Ensembl genes (13,016 with gene symbols), repre-
senting a large portion of the known transcriptome. Of the significant ER-level
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Figure 2.5: Principal components analysis reveals clusters of samples in the
BrainSpan data set. (Left) First two principal components (PCs) with samples colored
by sample type (F: Fetal or P: Postnatal) and shape given by brain region using only
the strictly intronic expressed regions (ERs). Analysis of other subsets of ERs produce
similar results (Supplementary Figure 2.9). (Right) Boxplots for PCs 1 and 2 by brain
region (NCX: neocortex, HIP: hippocampus, AMY: amygdala, STR: striatum, MD:
thalamus, CBC: cerebellum) and sample type with non-neocortex brain decomposed
into its specific regions. Using the single base-level approach (Supplementary Figure
2.10) produces similar results as shown in Supplementary Figure 2.11.
(Supplementary Section 2.11.4). Lack of overlap results from almost half
(45.2%) of single base-level DERs having an average coverage lower than the
expression cutoff determining ERs (0.25). For example, there was high expres-
sion only in the samples from a few brain regions, or only one development
period. Decreasing the cutoff that defines the ERs from 0.25 to 0.1 results in a
larger number of regions (217,085) that have a higher proportion of non-exonic
sequence (12.1%), suggesting that the choice of this expression cutoff requires
some initial exploratory data analysis as shown in Supplementary Section
2.11.5.
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We highlight the utility of the ER-level analysis (using the original 0.25
cutoff) to identify regions differentially expressed within subsets of the data
by analyzing brain regions within a single developmental period. We identi-
fied 1,170 ERs that were differentially expressed comparing striatum versus
hippocampus samples in the fetal developmental stage. These DERs mapped
to 293 unique genes. Genes more highly expressed in the striatum include
ARPP-21, previously shown to localize in the basal ganglia [41], and dopamine
receptor genes DRD1 and DRD2 [42]. Genes more highly expressed in the
hippocampus in fetal life were strongly enriched for neurodevelopmental
genes including FZD7 [43], ZBTB18 [44], and NEUROD1 [45]. The ER-level
analysis therefore permits subgroup analysis without the need to rerun the
full derfinder single base-level pipeline - another improvement over previous
versions of single base resolution analysis software [19].
DERs are non-standard in the sense that they don’t necessarily match with
known exons. Depending on the application, you might interested in filtering
out DERs that overlap problematic regions of the genome. This can be done
prior to defining the ERs or once the candidate DERs have been identified. In
the BrainSpan application, only 0.086% of the 129,278 DERs overlap ENCODE
blacklisted regions [4] and 1.58% overlap lincRNAs. Similarly one can check if
the DERs overlap other known features of interest. The genes overlapped by
the DERs are enriched for gene ontology terms such as neuron differentiation
(GO:0030182, p-value 4.13e-15), neurogenesis (GO:0022008, p-value 4.62e-14)
and neuron projection development (GO:0031175, p-value 1.4e-12) among other
terms associated to neuronal development.
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2.4.7 Identification of expressed regions that differentiate tis-
sues using a subset of the GTEx data
Figure 2.6: GTEx expressed regions analysis using 24 samples from the heart (left
ventricle), liver and testis for 8 subjects. A expressed regions (longer than 9 bp) over-
lapping known annotation based on GRGh38.p5 (hg38). 72.6% of the ERs only overlap
known exons (strictly exonic) while 10.4% only overlap known introns (strictly in-
tronic). B First two principal components (PCs) with samples colored by sample
type (red: liver, blue: heart, green: testis) using only the strictly exonic ERs. C First
two PCs with samples colored by sample type using only only the strictly intronic
ERs. The sign change of the second principal component is simply a rotation and the
results are consistent between the strictly exonic and strictly intronic ERs.
We selected a subset of subjects from the GTEx project [3] that had RNA-seq
data from heart (left ventricle), liver and testis, specifically the eight subjects
with samples that had RNA Integrity Numbers (RINs) greater than 7, given
RIN’s impact on transcript quantification [46]. Using only one sequencing
library from each subject aligned with Rail-RNA [26], we applied the ER-level
derfinder approach with a cutoff of 5 normalized reads (after normalizing
coverage to libraries of 40 million reads). We found a total of 163,674 ERs
with lengths greater than 9 base-pairs. Figure 2.6A shows that 118,795 (72.6%)
of the ERs only overlapped known exonic regions of the genome using the
Ensembl GRCh38.p5 database [47].
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we performed PCA on the log2 adjusted coverage matrix using just the
118,795 strictly exonic ERs (Figure 2.6B). Here the first two PCs explain 56.8%
and 21.6% of the variance respectively and show three distinct clusters of
samples that correspond to the tissue of the sample. We found that the
16,985 (10.4%) ERs (Figure 2.6A) that only overlap annotated introns can also
differentiate tissues using PCA, as shown in Figure 2.6C. The total percent
of variance explained by the first two principal components is slightly lower
(44.4% + 26.6% = 71% versus 56.8% + 21.6% = 78.4%) when using only the
strictly intronic ERs versus the strictly exonic ERs. This may represent a
different biological signal and/or potentially noisy splicing (as in Figure 2.3B).
but we use this example to illustrate the potential to use derfinder to explore
regions outside of known annotation.
Using limma [16, 15] to test for differential expression between tissues
(Methods Section 2.3.4.2) we found that 42,880 (36.1%) of the strictly exonic
ERs and 4,401 (25.9%) of the strictly intronic ERs were differentially expressed
(FWER of 5% via Bonferroni correction). Overall 59,776 (36.5%) of the ERs were
differentially expressed between tissues. Given the similar global patterns
of expression between annotated and unannotated ERs, we considered the
scenario that the strictly intronic ERs were differentially expressed between
tissues in the same pattern as the nearest exonic ERs due to possible run-off
transcription events. To assess this scenario we fitted a conditional regression
for each strictly intronic ER adjusting for the coverage of the nearest strictly
exonic ER. 749 (4.4%) of the strictly intronic ERs differentiate tissues while































































































































































































Figure 2.7: Differential expression on strictly intronic expressed regions adjusting
for expression on the nearest strictly exonic ER. Boxplots (A and C) and region
coverage plots (B and D) for two strictly intronic ERs showing differential expression
signal adjusting for the nearest exonic ER. Boxplots show the log2 adjusted coverage
for the strictly intronic ERs by tissue with the corresponding boxplot for the nearest
strictly exonic ERs. The p-value shown is for the differential expression between
tissues on the intronic ERs conditional on the expression values for the nearest exonic
ERs. The distance to the nearest strictly exonic ER and the gene symbol are shown
below. The region coverage plots are centered at the strictly intronic ER with the
neighboring 2kb and 5kb for C and D respectively. A,B Expression on the exonic ER is
fairly similar between the groups but different on the intronic ER. C,D Expression on
the exonic ER has an increasing pattern from heart to liver to testis but has a different
pattern on the intronic ER.
2.7A,B shows an example where the expression is similar between tissues in
the nearest exonic ER but there is a clear tissue difference in the intronic ER
with testis having higher expression than the other two tissues. Figure 2.7C,D
shows different patterns between the intronic and exonic ERs where in the ex-
onic ER the expression is lowest in the heart, higher in liver and slightly higher
at the testis. However in the intronic ER, liver is the tissue that has the lowest
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expression. These results suggest that expression at unannotated sequence
could have biological relevance beyond local annotated exonic sequence.
2.4.8 Simulation results
We lastly performed a simulation study to evaluate the statistical properties
of derfinder with and without complete annotation. To compare derfinder
against feature-level alternatives, we simulated reads for 2 groups, 10 samples
in total (5 per group) with 16 of the transcripts having higher and
1
6 lower
expression in group 2 versus group 1 at fold changes of 2x and 12x respectively.
Reads were simulated from chromosome 17 using polyester [28] with the
total number of reads matching the expected number given paired-end library
with 40 million reads (Methods Section 2.3.4.3). We used HISAT [29] to align
the simulated reads and summarized them using either featureCounts from
the Rsubread package [13] or StringTie [23] and performed the statistical
tests on the resulting coverage matrices using limma and ballgown [22] re-
spectively. We performed the ballgown statistical test at the exon-level as
well as the transcript-level. We performed the feature-level analyses using
the complete annotation and with an annotation set missing 20% randomly
selected transcripts (8.28% unique exons missing). We then used derfinder to
find the ERs from the same HISAT alignments as well as from Rail-RNA [26]
output and performed the statistical test with limma. For all statistical tests we
controlled the FDR at 5% and we repeated the simulation three times.














































































































































































































































































































































































































































































































































and false discovery rate (FDR) for all these methods based on the three sim-
ulation replicates. derfinder’s expressed region approach resulted in over-
lapping empirical power ranges to the exon-level methods that are supplied
the complete annotation. The exon-level methods had a 18% to 27% loss in
power when using the incomplete annotation set compared to the complete
set even though only 8.28% of the unique exons were missing. derfinder,
being annotation-agnostic, does not rely on having the complete annotation
but did show increased FPR and FDR compared to the exon-level methods.
We recommend performing sensitivity analyses of the cutoff parameter used
for defining ERs or the FDR control in the statistical method used to determine
which ERs are differentially expressed (i.e. DERs). Transcript-level analyses
had the lowest FPR and FDR but also the lowest power. Note that we only
performed transcript expression quantification with StringTie and did not
use the data to determine new transcripts. Doing so resulted in a much larger
transcript set than originally present in the data: 3,900 in the original set
versus 15,920 (average for the three replicates using the complete annotation).
Supplementary Section 2.11.6.1 shows the results when using DEseq2 or
edgeR-robust for performing the statistical tests. Figure 2.8 shows the mean
empirical power against the observed FDR for the different combinations of
methods when controlling the FDR at 1%, 5%, 10%, 15% and 20%. Results
with derfinder are among the set with the highest empirical power, at the
cost of a higher observed FDR than what was controlled for.
Identifying ERs uses computational resources and runs in similar time
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Figure 2.8: Mean empirical power versus observed False Discovery Rate (FDR)
across the 3 simulation replicates for a combination of statistical and summary
methods. For FDR cutoffs of 1, 5, 10, 15 and 20% the mean empirical power and FDR
across the 3 simulation replicates is displayed for the combination of statistical method
(ballgown at exon or transcript level, limma, DESeq2, edgeR-robust) the summary
method (derfinder, featureCounts (fC), StringTie (sT)) and whether the annotation
used was complete or not (complete, incomplete).
simulation (Supplementary Section 2.11.6.2) and is the fastest when using
BigWig files such as those produced by Rail-RNA. These results suggest that
the derfinder approach performs well when differentially expressed features
overlap known annotation and appear in unannotated regions of the genome.
If you are only interested in studying known regions, other methods have
better FDR control than derfinder as shown in Figure 2.8.
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2.5 Discussion
Here we introduced the derfinder statistical software for performing genome-
scale annotation-agnostic RNA-seq differential expression analysis. This ap-
proach utilizes coverage-level information to identify differentially expression
regions (DERs) at the expressed region or single base-levels, and then gener-
ates useful summary statistics, visualizations and reports to further inspect
and validate candidate regions.
The reduced dependence on the transcriptome annotation permits the
discovery of novel regulated transcriptional activity, such as the expression
of intronic or intergenic sequences, which we highlight in publicly available
RNA-seq data and our previous derfinder application [20]. As shown with
a subset of GTEx, strictly intronic ERs can differentiate tissues when adjust-
ing for the expression from the nearest exonic expressed region, suggesting
that some intronic DERs may represent signal beyond run-off transcription.
Furthermore, the structure of DERs across a given gene can permit the direct
identification of differentially expressed transcripts (e.g. Figure 2.2C), provid-
ing useful information for biologists running validation experiments. Lastly,
this software and statistical approach may be useful for RNA-seq studies on
less well-studies species, where transcript annotation is especially likely to be
incomplete.
The software pipeline, starting with BAM or BigWig files, and ending with
lists of DERs, reports, and visualizations, runs at comparable speeds to exist-
ing RNA-seq analysis software. Given the appropriate computing resources,
derfinder can scale to analyze studies with several hundred samples. For
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such large studies, it will be important to correct for batch effects and po-
tentially expand derfinder’s statistical model for base-level covariates. This
approach provides a powerful intermediate analysis approach that combines
the benefits of feature counting and transcript assembly to identify differential
expression without relying on existing gene annotation.
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2.10 Additional Files
The derfinder vignettes detail how to use the software and its infrastruc-
ture. The latest versions are available at www.bioconductor.org/packages/
derfinder.
The Supplementary Methods and Results describe in more detail the R im-
plementation, the single base-level approach, and the analysis of the BrainSpan
data set with the single base-level approach. Supplementary file 1 contains the
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identified candidate single base-level DERs in CSV format (gzip compressed)
for the BrainSpan data set.
The code and log files detailing the versions of the software used for all
the analyses described in this paper is available at the Supplementary Website:
leekgroup.github.io/derSupplement.
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Supplementary Methods and Results
This document describes R implementation details of derfinder, the single
base-level approach, and results from applying the single base-level approach
to the BrainSpan data set. It also includes the simulation results when perform-




The derfinder package can be used for different types of analyses such as
DER finding (single base-level and ER-level approaches) as well as creating
a feature counts matrix. The overall relationship between these functions is
shown in section Flow charts subsection DER analysis flow chart of the derfinder
users guide vignette available at www.bioconductor.org/packages/derfinder.
For the single base-level approach, the main function is analyzeChr()
which makes it easier for users to run this type of analysis. This function is a
wrapper for other functions available in derfinder, as can be seen section Flow
charts subsection analyzeChr() flow chart of the derfinder users guide vignette.
It splits the data, calculates the F-statistics, identifies the null regions, and
annotates them.
The expressed regions (ERs) approach is described in section Flow charts
subsection regionMatrix() flow chart of the derfinder users guide vignette. This
type of analysis requires fewer functions, as the user only needs to load the
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data and then identify the ERs with the regionMatrix() function. The re-
gionMatrix() flow chart shows which other functions are internally used by
regionMatrix() that filter the coverage by using a mean cutoff, identify the re-
gions, and produce the region-level count matrix. The function railMatrix()
is optimized for identifying ERs from BigWig files, specially those created
with Rail-RNA (DOI: 10.1101/019067).
2.11.2 Differential expression in the developing human brain
via expressed region-level analysis
Figure 2.9 complements Figure 2.5 with the results of performing principal
component analysis of ERs found in the BrainSpan data set given the known
annotated elements they overlap with. The results are consistent regardless of
the type of ERs under study.
2.11.3 Single base-level statistical test
A single base-level resolution analysis in derfinder starts with read align-
ment and coverage calculation as done in the ER-level approach. Next, a
standard differential expression analysis is performed at each base by com-
paring nested null and alternative linear models using an F-statistic. The
statistical models may include adjustments for confounders such as library
size [48], demographic variables, and batch effects [40].
Once an F-statistic is calculated at each base, we identify differentially
















































































































































































































































































PCA of Expressed Regions (Exonic)
























































































































































































































































































































PCA of Expressed Regions (Intergenic)



























































































































































































































































































PCA of Expressed Regions (All)









































































































































































































































































PCA of Expressed Regions (Exon+Intron)





















Figure 2.9: Principal components analysis reveals clusters of samples in the
BrainSpan data set. First two principal components (PCs) with samples colored
by sample type (F: Fetal or P: Postnatal) and shape given by brain region using all ERs
(top left), strictly exonic ERs (top right), ERs overlapping exons and introns (bottom
left) and strictly intergenic ERs (bottom right).
find candidate DERs by identifying regions of the genome where the base-
level F-statistics pass a genome-wide threshold (Figure 2.10 with BrainSpan
data set, see Supplementary Section 2.12.1). We then calculate a summary
statistic for each candidate region based on the length of the region and the
44
size of the statistics within the region. To evaluate the statistical significance
of these candidate regions, we permute the sample labels and recompute
candidate regions and summary statistics. The result is a region-level p-value,
which can be adjusted to control the family-wise error rate. Alternatively, the
region-level p-values can be adjusted for multiple testing using standard false
discovery rate techniques [49, 50].
2.11.4 Differential expression in the developing human brain
via single base-level analysis
At the single base-level, we identified 113,691 genome-wide significant DERs
(FWER < 5%) with the same statistical models used with the ER-level analysis
described in the main text. These resulting single base-level DERs largely
distinguished the fetal and postnatal samples representing the first principal
component and 49.4% of the variance of the mean coverage levels within
the DERs (Figure 2.11). The most significant DERs map to genes previously
implicated in development, and contained many of the DERs we previously
identified in the frontal cortex in 36 independent subjects [20]. For example,
59% of our previously published 50,650 developmental DERs (and 72.6% in the
10,000 most significant) in the frontal cortex overlapped these DERs identified
in the BrainSpan data set. The potential lack of overlap may be explained by
unmodeled artifacts as there appear to be clusters in the principal components
calculated on the base resolution data (Figure 2.11, left panel).
While the majority (68.1%) of single base-level DERs overlap exclusively
exonic sequence using Ensembl database v75, we find that a fraction (22.2%)
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Figure 2.10: Finding DERs on chromosome 3 with BrainSpan data set using six
groups: Neocortical regions (NCX: DFC, VFC, MFC, OFC, M1C, S1C, IPC, A1C, STC,
ITC, V1C), Non-neocortical regions (NonNCX: HIP, AMY, STR, MD), and cerebellum
(CBC) split by whether the sample is from a fetal (F) or postnatal (P) subject. A
Boxplots for three specific bases. B F-statistics curve with regions passing the F-stat
cutoff marked as candidate DERs. C Raw coverage curves superimposed with the
candidate DERs. D Known exons (dark blue) and introns (light blue) by strand. The




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2.11: Principal components analysis reveals clusters of samples in the
BrainSpan data set. (Left) First two principal components (PCs) with samples col-
ored by sample type (F: Fetal or P: Postnatal) and shape given by brain region. (Right)
Boxplots for PCs 1 and 2 by brain region (NCX: neocortex, HIP: hippocampus, AMY:
amygdala, STR: striatum, MD: thalamus, CBC: cerebellum) and sample type with
non-neocortex brain decomposed into its specific regions.
of the single base-level DERs map to sequence previously annotated as non-
exonic (e.g. solely intronic or intergenic). The proportion of exonic sequence is
higher than our previous analyses in the frontal cortex [20]. When the single
base-level DERs are stratified by brain region and developmental period
with the highest expression levels (Table 2.2), we find the highest degree of
unannotated regulation in the cerebellum, the brain region with the largest
degree of region-specific genes in a previous analyses [51]. The majority of
DERs, regardless of their annotation, are most highly expressed in fetal life,
particularly within the neocortex, hippocampus, and amygdala. Non-exonic
expression might be due to incomplete transcript annotation in reference
databases, background expression, or previously undetected artifacts.
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Table 2.2: Classification of single base-level DERs in the BrainSpan project. For each
statistically significant DER, we identified the developmental period and region with
the highest average expression levels, stratified by annotation relative to the Ensembl
gene database. NCX: neocortex, HIP: hippocampus, AMY: amygdala, STR: striatum,
MD: thalamus, CBC: cerebellum. Region assignment is prioritized by exon > intron
> intergenic.
Group Exonic Intergenic Intronic Total
NCX Fetal 15583 1946 1196 18725Postnatal 2750 882 415 4047
HIP Fetal 12511 889 523 13923Postnatal 1021 237 144 1402
AMY Fetal 14705 1178 727 16610Postnatal 1193 229 167 1589
STR Fetal 6952 1706 1199 9857Postnatal 4734 1060 905 6699
MD Fetal 4671 890 431 5992Postnatal 2922 425 348 3695
CBC Fetal 9984 1815 1118 12917Postnatal 11382 2932 3921 18235
2.11.5 Exploratory analysis of the cutoff used for the expressed
regions-level analysis in the developing human brain
The cutoff used in the expressed regions-level derfinder analysis impacts
how many ERs are found (Figure 2.12A), their length in base pairs (width,
Figure 2.12B). It can also affect the percent of the known annotation that at
least overlaps one ER (Figure 2.12C) and conversely the percent of ERs that
overlap at least one known exon (Figure 2.12D). Figure 2.12 shows the effect
of the cutoff used with the BrainSpan data set for a range of cutoffs from 0.025
to 0.5 in increments of 0.025. Note that this data set was already normalized
to a library size of 1 million reads. We recommend choosing a cutoff in the
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elbow of these curves. In Section 2.4.6 we present the results for cutoffs 0.1
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Figure 2.12: Exploratory analysis of the expressed regions cutoff used for the
BrainSpan data set. A Relationship between number of ERs of at least 6 base-pairs in
length against the cutoff used in Figure 2.2A. B Distribution of the width of the ERs
for each cutoff summarized by quantiles in 10% increments and log10 transformed. C
Percent of ENSEMBL v75 exons overlapping at least one ER by cutoff. D Percent of
ERs overlapping at least one ENSEMBL v75 exon by cutoff.
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2.11.6 Simulation analysis
2.11.6.1 Simulation results with DESeq2 or edgeR-robust
Table 2.3 shows the empirical power, false positive rate (FPR) and false discov-
ery rate (FDR) for the different analysis pipelines that result in a count matrix
which we analyzed with DESeq2 [14] or edgeR-robust [18] while controlling
the FDR to 5%. The observed power for edgeR-robust is slightly higher than
the corresponding results using DESeq2 [14]. The observed FPR and FDR with
edgeR-robust are higher than in the DESeq2 results, with overlapping ranges
for the derfinder analyses and non-overlapping ones when summarizing the
data with featureCounts [13].
2.11.6.2 Timing and computational resources used
Table 2.4 shows a summary of the computational resources used for the
different pipelines used in the simulation as well as the time for running them.
In general, the maximum memory per core is low (most are below 3.2 GB)
regardless of the analysis step. The exception is alignment with Rail-RNA
because of how our computing cluster measures memory usage: it artificially
increases when processes spawn shared-many sub-processes by counting
more than once the memory used by shared objects. Time-wise all analysis
steps except for alignment take only 11 minutes at most. Notably, the ER-level
approach is much faster with Rail-RNA output than with HISAT output. This is
because derfinder can load the data much faster from BigWig files than from
BAM alignment files and the railMatrix has been optimized for the BigWig































































































































































































































































































































































































































































































































































than HISAT for aligning reads, but this is expected since Rail-RNA is better
suited at analyzing larger data sets in the cloud and decreasing false positives
when determining new splice junctions. This is reflected on Table 2.1 and 2.3
with slightly reduced FPR and FDR when using Rail-RNA compared to HISAT.
The timing results for each computing job are available in the Supplementary
Website.
Table 2.4: Summary of computing resources required for each analysis step for the
different simulation pipelines. This table shows the maximum memory (GB) per
core, the time in minutes to run the analysis with all jobs running sequentially and
the maximum number of cores used in any step of the simulation analysis for the
different pipelines. Note that the ERs (H), the feature-level counts and ballgown








(2.8-3.1) (2.1-3.2) 10 ER-level (R) Align prep
(32.8-39.1) (137.6-218.4) 10 ER-level (R) Align
(3.2-3.2) (47.2-72.1) 40 HISAT Align
(1.4-1.4) (1.5-1.5) 1 ER-level (R) Summarize
(0.6-0.6) (1.3-1.9) 1 ER-level (R) Statistical tests
(0.8-0.8) (5-7) 4 ER-level (H) Summarize
(0.6-0.6) (1.5-1.9) 1 ER-level (H) Statistical tests
(2.2-2.2) (1.6-1.6) 8 Feature
counts
Summarize
(0.6-0.6) (3.7-5.3) 2 Feature
counts
Statistical tests
(2.1-2.1) (8.7-11) 80 StringTie
Ballgown
Summarize





2.12.1 single base-level derfinder
The single base-level approach implemented in derfinder requires two mod-
els. The alternative model (3.2) contains an intercept, the primary covariate
of interest, and optionally adjustment variables. The primary variable can be
as simple as a case-control variable or a more complicated model including
smoothing functions (e.g. splines) over time. The adjustment variables can
include a library size normalization factor for raw data and optionally other
potential confounders like age, sex, and batch variables. There are differ-
ent library size normalization factors you can consider using and derfinder
implements a version in the sampleDepth function based on Paulson et. al
[52].








γiqZjq + ϵij (2.3)
In both models yij is the scaled log2 base-level coverage for genomic po-
sition i and sample j. That is, yij = log2
(
coverageij + scaling factor
)
. The
model is completed by the n group effects fii, m adjustment variable effects fli
and potentially correlated measurement error ϵ. The null model (3.1) is nested
within model (3.2) and contains only the intercept and adjustment variables.




γiqZjq + ϵij (2.4)
derfinder uses a fixed design matrix, testing the same hypothesis at every
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base. This permits fast vectorized differential expression analysis. At each base
we compute a moderated F-statistic [16] of the form in equation (2.5), where
RSS0i and RSS1i are the residual sum of squares of the null and alternative
models for base i. Furthermore, df0 and df1 are the degrees of freedom for the
null (3.1) and alternative (3.2) models respectively, n is the number of samples,
and an offset can be used for smaller experiments to shrink large F-statistics
that may be driven by few biological replicates that cluster tightly.
Fi =
(RSS0i − RSS1i)/(df1 − df0)
offset + (RSS1i/(n − df1))
(2.5)
We then perform “bump hunting” adapted to Rle objects in order to
identify candidate DERs, Rk. Candidate DERs are defined as contiguous
sets of bases where Fi > T for a fixed threshold T. We then calculate an “area”
statistic for each candidate DER which is the sum of the F-statistics above the
threshold within the region: Sk = ∑j∈Rk Fj (Figure 2.10B). We have previously
applied this approach to identify local differentially and variably methylated
regions and more long range changes in methylation [33, 53, 54]. One key
difference compared to previous implementations in DNA methylation data is
that we do not explicitly smooth the F-statistics, allowing for precise discovery
of intron-exon boundaries in the data (Figure 2.10C).
Permutation analysis generates statistical significance for each of these
candidate DERs by permuting the sample labels, re-calculating the F-statistics,
identifying null candidate regions and region-level statistics in this permuted
data set, and then calculating empirical p-values and/or directly estimating
the family-wise error rate (FWER) [33]. Alternatively, the empirical p-values
54
can be adjusted to control the false discovery rate (FDR) via qvalue [49].
2.12.2 Data Processing: BrainSpan data
For the single base-level analysis, we used a scaling factor of 1 and chose the
F-statistic cutoff T such that P(F > T) = 10−6. We used the same alternative
model described for the expressed region analysis in the main text. We com-
pared the alternative model to an intercept-only model, and identified DERs
using the single base-level analysis. We then calculated the mean coverage for
each significant single base-level DERs in each sample, resulting in a mean
coverage matrix (DERs by samples), and we performed principal component
analysis (PCA) on this log2-transformed matrix (after adding an offset of 1),
which were subsequently plotted in Figure 2.11.
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Chromatin immunoprecipitation followed by sequencing (ChIP-seq) ex-
periments identify regions of the genome with binding signal for a protein of
interest. When multiple samples are collected for different conditions, treat-
ments or other covariates, researchers will ask if there is differential binding
between these conditions. The current strategies for answering this question
rely on merging peaks from the different samples which can lead to un-wanted
issues. These strategies do not take into account the variability across samples
when merging peaks.
Results
Here we show that the Bioconductor package derfinder can be used to
identify differentially bound peaks using ChIP-seq data, bypassing the peak
calling step. The software is flexible, annotation-agnostic and takes into
account the variability across all samples in determining differentially bound
peaks. We illustrate the approach using ChIP-seq data from the EpiMap study
for histone marks H3K4me3 and H3K27ac from the human brain. We identify
differentially bound peaks associated with cell type, brain region and/or age
at time of death. We show that most of the differentially bound peaks are
associated with cell type, although some are also associated with technical
covariates. We compare our approach to results from DiffBind, one of the
most widely used software for differential binding analysis.
Conclusions
derfinder can be successfully used to identify differentially bound peaks
using ChIP-seq data. This approach solves the merging peaks problem where
you have to choose between analyzing wide peaks or peak summits.
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The package is available at www.bioconductor.org/packages/derfinder.
Keywords ChIP sequencing, differential binding analysis, ChIP-seq, ATAC-
seq, ChIP-exo, DNase-seq.
3.2 Introduction
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is the
main assay used to identify regions of the genome where a given protein of
interest binds to the genome. For example ChIP-seq can be used with transcrip-
tion factors to identify transcription factor binding sites. ChIP-seq experiments
nowadays are widely used as the technology has benefited from decreased
sequencing costs. These experiments typically produce high-throughput short
sequence reads for samples of interest as well as control input samples. The
control input samples can be used by peak caller software to adjust for po-
tential noise from the immunoprecipitation step. Model-based Analysis for
ChIP-seq (MACS) [1] is one of the most commonly used peak callers and is
among the best as evaluated with different metrics [2].
ChIP-seq experiments can be used to identify differential binding peaks
between two conditions or more complicated designs. The analysis pipeline
for determining differential binding peaks typically begins by using a peak-
caller such as MACS [1] for each sample (Figure 3.1A). Once the peaks for
each sample have been identified, the next step is to merge them to build a
consensus peak set (Figure 3.1B) using custom scripts or software such as
DiffBind [3, 4], diffReps [5], among others [6]. A count matrix based on this
consensus peak set is then constructed in a similar process to how RNA-seq
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count matrices are created. Then this count matrix is analyzed with software
for differential expression analysis such as DESeq2 [7]. Alternatively, window
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Figure 3.1: Current strategy for identifying differentially bound peaks between
two conditions. (A) A peak-caller is used independently for each sample from both
groups to identify peaks. (B) The peaks from all samples are merged to determine
a common set across all samples. (C) For each merged peak, a statistical test is per-
formed to determine whether the peak is differentially bound between the conditions.
The current strategy for identifying differentially bound peaks does not
take into account the variability across samples for determining peaks. This
strategy also ignores the variability among samples when merging. The
merging step is performed by sequentially identifying which unique peaks
overlap with each other (Figure 3.2A). These can lead to wide consensus
peaks as shown in Figure 3.2B for the consensus peak with the highest fold
65
change that increased over time for time-course ChIP-seq experiment [9]. This
widening effect can be limited by identifying the base-pair with the highest
coverage among all samples called summit in DiffBind [3] and using only a
fixed window size surrounding this peak.
























































Figure 3.2: Merging peaks by overlaps can lead to wide peaks. (A) Peaks are
merged sequentially by finding other peaks than overlap them, which can lead
to two non-overlapping peaks being merged into the same merged peak. (B) Example
of a wide merged peak with strong coverage support in the middle region of the peak
and low support on the ends. Samples are colored by age group.
Here we show that derfinder [10] can be used to directly identify the
differentially bound peaks with minor alterations to the pipeline used for
RNA-seq data as shown in Figure 3.3. We illustrate our proposed strategy
using ChIP-seq samples for histone marks H3K4me4 and H3K27ac from the
human brain. Using derfinder for identifying differentially bound peaks
skips the traditional peak calling step.
The differentially bound peaks (dbPeaks) identified with derfinder have
differential binding signal support for all bases, which is not necessarily true
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for current strategies (Figure 3.2B). Furthermore, by calculating F-statistics
derfinder does take into account the sample variability across each base-
pair when determining the dbPeaks. The proposed strategy does not rely on
input samples since it does not identify peaks per sample. Strategies that rely
on input samples can be noisy since many input samples show anomalous
signal in some regions. This problem can be addressed using software such
as GreyListChIP [11]. While derfinder is not a peak caller, given several
replicate input runs derfinder could be used to identify differential binding
between samples and input for peak calling.
3.3 Results
3.3.1 Finding differentially bound peaks with derfinder
The DER Finder methodology [12] was initially designed to identify differen-
tially expressed regions with RNA-seq data without relying on annotation.
derfinder [10] implements this method in two approaches. The single base-
level approach is based on calculating F-statistics at every single base-pair
of the genome where enough input signal is available. It aims to find sharp
boundaries which is a desired feature given the nature of RNA-seq data. We
modified the single base-level approach for ChIP-seq data, and in general any
genomic data type where the regions of interest do not have sharp boundaries.
First, we define two models: an alternative and a null model. Using
these models we calculate F-statistics at every base as shown in Figure 3.3A
which take into account the sample variability. This results in a F-statistic
curve along the genome as shown in Figure 3.3B. With RNA-seq data, we
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would then determine differentially expressed regions at that point using
a global cutoff based on the distribution of the F-statistics. For ChIP-seq
data, we perform a smoothing step to the F-statistic curve as shown in Figure
3.3C. We then determine the differentially bound peaks using a global cutoff.
Once the differentially bound peaks (dbPeaks) have been identified, we can
identify where the dbPeaks are located in the genome and visualize them
using derfinderPlot [13] as shown in Figure 3.3D-F.
derfinder is very flexible and can identify differentially bound peaks
using different models. It can be used for time-course ChIP-seq experiments
and does not rely on input samples for determining the differentially bound
peaks. Technical details are described in Methods Section 3.5.1.
3.3.2 Differentially bound peaks for histone marks H3K4me3
and H3K27ac in the human brain
To illustrate our approach for identifying differentially bound peaks with
derfinder, we used 62 and 57 ChIP-seq samples from the EpiMap study [14]
for histone marks H3K4me3 and H3K27ac, respectively. Using fluorescence-
activated cell sorting, 31 and 28 of the samples were determined to be negative
for the NeuN antibody, respectively for H3K4me3 and H3K27ac. For both
histone marks, 29 of the samples are from anterior cingulate cortex (ACC) with
the remaining samples extracted from the dorsolateral prefrontal complex
(DLPFC). Details are shown in Table 3.1 and Supplementary Methods 3.10.
For each histone mark, we used derfinder’s single base-level approach
to identify differentially bound peaks (dbPeaks) for the 8 groups given by
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Figure 3.3: Identification of differentially bound peaks with derfinder. A Boxplots
of the coverage for 4 consecutive bases with the F-statistic for difference between
the 8 groups. B F-statistic curve across a window of chromosome 1. C Smoothed
F-statistic curve across the same window. Regions above the cutoff are labeled as
candidate differentially bound peaks (dbPeaks). D Raw sample coverage plots with
candidate dbPeaks highlighted. E Known gene and F transcripts for this window
of chromosome 1. Known exons (dark blue) and introns (light blue) are shown by
strand. The data is from the H3K4me3 histone mark.
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Table 3.1: Sample information from the EpiMap study for histone marks H3K4me3


















cell type, brain region, and age at time of death. We smoothed the F-statistics
using a window of 300 base-pairs. We then identified the set of candidate
dbPeaks with a family-wise error rate (FWER) adjusted p-value less than
0.05. This resulted in 29,939 and 204,026 dbPeaks for H3K4me3 and H3K27ac
histone marks with median lengths of 1,292 and 1,135 base-pairs, respectively.
The minimum and maximum lengths in base-pairs are 182 and 24,598 for
H3K4me3 and 141 and 65,971 for H3K27ac.
The dbPeaks for these histone marks overlap in different ways Ensembl
v75 [15]’s features as shown in Figure 3.4. For the histone mark H3K4me3,
the dbPeaks overlapping known exons and introns are the most frequent
group (33%, Figure 3.4A) and span 20.5 mega base-pairs (mb) of the genome
representing 38.95% of all bases spanned by these dbPeaks. For H3K27ac,
most of the dbPeaks overlap exclusively known intronic regions (51.1%, Figure
3.4B) and in total the dbPeaks cover a much larger portion of the genome:
347.9 versus 52.6 mb. For both histone marks, dbPeaks that overlap all types
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of features show an increase in percent of the total by length of the genome
spanned with respect to the total number of peaks (1.42 and 2.67 fold change).
This is expected since the peaks have to be long to cover all three types of
features.















































Figure 3.4: Overlap between differentially bound peaks for H3K4me3 and
H3K27ac marks and Ensembl v75 features. Overlaps are shown in venn diagrams
for (A) H3K4me3 and (B) H3K27ac differentially bound peaks (dbPeaks) by cell type,
brain region or age at death. Percent of dbPeaks and total mega base-pairs spanned
are shown below the number of dbPeaks.
3.3.2.1 Characterization of differentially bound peaks by modeled covari-
ates
For each of histone marks we calculated a count matrix summarizing the
base-level information as described in Methods Section 3.5.2. Using this log2-
transformed matrix, we fit a linear model to using an intercept term and one
of the main covariates: brain region, cell type, or age at death (continuous).
For each covariate we identified the dbPeaks that are significantly associated
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(FWER < 0.05) with the covariate. 89.2% and 94.5% of the dbPeaks are only
associated with cell type for H3K4me3 and H3K27ac (Figure 3.9).



















































































































































Figure 3.5: Boxplots showing the first principal component for dbPeaks with sig-
nificant associations with a modeled covariate. (A) H3K4me and (B) H3K27ac db-
Peaks associated with brain region (1), cell type (2) and age at death (3). ACC samples
are shown in blue, DLPFC samples in green. NeuN- samples are shown with circles,
NeuN+ samples with squares. Darker colors and lighter colors are used for sam-
ples below and above the median age at time of death, respectively. The number of
dbPeaks for each principal component analysis is given in Figure 3.9.
For the dbPeaks associated with each of the modeled covariates (brain
region, cell type, age at death), we performed a principal component analysis
using the log2-transformed matrix. For H3K4me3, the first principal com-
ponent (PC) explains at least 67.8% of the variance (Figure 3.5A) while the
equivalent analysis for H3K27ac showed that the first PC explains at most
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60% of the variance (Figure 3.5B). For age at death, this drop can be explained
by a decrease in the percent of dbPeaks strictly associated with age at death
between H3K4me3 and H3K27ac (Figure 3.9). When performing the principal
component analysis with all dbPeaks, the first PC explains 77.9% and 58.8% of
the variance for H3K4me3 and H3K27ac dbPeaks and is markedly associated
with cell type.
3.3.2.2 Example differentially bound peaks highlight problems with the
current strategy for merging peaks
Figure 3.6: Coverage plots for average coverage levels for differentially bound
peaks. (A) The sixth strongest H3K4me3 dbPeak and (B) second strongest H3K27ac
dbPeak associated with cell type. (C) and (D) are two other H3K4me3 dbPeaks that
show differences by cell type. Lines are colored by group with NeuN- samples shown
in lighter colors. ACC and DLPFC abbreviated as A and D, NeuN- and NeuN+ as N-
and N+, and below or above the median age at time of death as - and +, respectively.
The strong association with cell type is remarkable when visually exploring
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the resulting dbPeaks as shown in Figure 3.6. For example, the dbPeak with
the sixth strongest association with cell type for H3K4me3 shown in Figure
3.6A and it overlaps RGAG1, a gene that has been associated to non-syndromic
X-linked intellectual disability [16]. The H3K27ac dbPeak shown in Figure 3.6B
overlaps SLC1A3, a gene that encodes a high affinity glutamate transporter
family known to be important for astrocytes [17].
In Figure 3.6 the mean coverage for all groups by cell type is very similar.
In Figure 3.6A the NeuN+ samples compose a coverage curve with multiple
summits and would likely be broken into different consensus peaks when
using DiffBind with the summits argument to control the widening effect of
the merging step. This could be a problem and it shows that with the current
strategy for identify differentially bound peaks an arbitrary choice leads to
either wide consensus peaks (Figure 3.2B), or to splitting peaks.
3.3.2.3 Variation in the differentially bound peaks
We produced a similar figure to Figure 3C from Geuvadis RNA-seq analysis
[18] and reproduced in Figure 3 of the Rail-RNA software paper [19]. For each
histone mark, we used the log2-transformed count matrix and fit a model
for each dbPeak with the 3 modeled covariates (brain region, cell type, age
at death) as well as 12 other covariates, some of which are biological (BMI,
sex) and some of which are technical such as flowcell batch and total mapped
reads. Figure 3.7 shows the percent of variance explained for all the dbPeaks
by each of these 15 covariates and the residual variation.
In contrast to the Geuvadis RNA-seq data [18, 19], residual variation is
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Figure 3.7: Boxplots of percentage of variation explained by the 3 modeled covari-
ates, 12 other covariates, and residual variation. Boxplots for (A) H3K4me3 and (B)
H3K27ac dbPeaks.
not the most important factor. This is expected since we are only analyzing
regions of the genome that showed differential binding by brain region, cell
type and/or age at death. For both histone marks, cell type explains most of
the variance and it does so more strongly for H3K4me3. Notably, the total
number of mapped reads explains more of the variability than brain region and
age at death. This effect is weaker for H3K27ac, whose samples were prepared
such that around 80 million uniquely mapping reads would be generated
versus 40 million H3K4me3. However, the effect of the individual, flowcell
batch and library batch covariates is stronger for H3K27ac than H3K4me3.
Overall, the technical covariates are more closely clustered in H3K27ac than
in H3K4me (Figure 3.11).
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In the Rail-RNA re-analysis, the figure did not show differences by annota-
tion features. Figure 3.10 shows the equivalent annotation breakdown, and
while most the picture is similar across annotation features there is a difference
in the percent of variance explained by the total mapped reads. This difference











































































(A) (B)STAG2 dbPeak by PMI LRIG1 dbPeak by mapped reads
Figure 3.8: Scatterplots between the total coverage (log2) and un-modeled covari-
ates. (A) H3K4me3 dbPeak from Figure 3.6C has the third strongest association with
post-mortem interval (PMI). (B) H3K4me3 dbPeak from Figure 3.6D has the fifth
strongest association with total mapped reads. The -log10 Bonferroni adjusted p-value
for adding PMI or total mapped reads to a model accounting for brain region, cell
type and age at death is shown. Colors and shapes are as described in Figure 3.5.
For each dbPeak and each of the 12 un-modeled covariates, we sequentially
fit a model testing the contribution of the un-modeled covariate against a null
model with brain region, cell type and age at death. We FWER adjusted the
resulting p-values and for each of the un-modeled covariates we identified
the set of dbPeaks significantly associated with said covariate (FWER < 0.05)
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controlling for brain region, cell type and age at death. Figure 3.8 shows two
H3K4me3 dbPeaks that are associated with post-mortem interval (PMI, Figure
3.8A) and the total number of mapped reads (Figure 3.8B); the -log10 p-value
is shown in each panel. These two dbPeaks overlap STAP2 associated with
T-cells [20] and LRIG1 that has been linked to inhibition of cancer cell growth
[21]. These dbPeaks are associated with cell type as shown in Figure 3.6C and
D, respectively. Notably, the cell type association is clear in Figure 3.8B with
no apparent interaction with the total number of mapped reads.
3.3.3 Comparison with DiffBind derived differentially bound
peaks
For each histone mark, we identified peaks using MACS [1] and performed the
differential binding analysis using DiffBind while controlling the FWER at
5% as described in Methods Section 3.5.4. We focused on DiffBind since it
is the most widely currently used software for differential binding analysis
and is one of the best performers for studies with biological replicates [6]. For
H3K4me3, 100,326 (70.6%) peaks were present in at least 2 samples (including
the input sample) out of 142,102 peaks. The corresponding number of peaks
for H3K27ac are 402,932 (71.2%) out of 565,787.
We ran the DiffBind analysis twice: once without restricting the analysis
to peak summits, and the second with 500 base-pair summits. The summit
windows significantly associated with cell type (FWER < 0.05) overlap 91.7%
and 92.95% of the time the differentially bound peaks as identified without re-
stricting DiffBind’s analysis to the peak summits for H3K4me3 and H3K27ac
respectively. The inverse is similar (92.16% and 95.17%), thus the DiffBind
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results are highly consistent regardless of how consensus peaks are derived.
We explored whether the candidate dbPeaks derived from derfinder and
DiffBind overlapped or not, alternating which set was used as the query
(reference) and which one was used as the target as shown in Table 3.2. For
H3K4me3 90.88% of the DiffBind consensus peaks derived without using
summits (wide peaks) overlap at least one candidate dbPeak from derfinder
(94.17% for H3K27ac). Thus most DiffBind consensus peaks are tested for
differential binding in both methods. However, the inverse is not true as only
47.15% of the candidate H3K4me3 derfinder dbPeaks overlap a peak tested
with DiffBind (42.12% for H3K27ac). These percents drop of when comparing
against the peak summits as expected by the fact that the peak summits are
mostly 500 base-pairs long.
When considering the significant dbPeaks (FWER < 0.05) from both meth-
ods, only 30.33% of DiffBind’s wide significant dbPeaks for H3K4me3 overlap
derfinder’s significant dbPeaks (37.56% for H3k27ac). This can be explained
by the fact that DiffBind labels as significant 69.4% and 76.8% of the consensus
wide peaks while derfinder determined that 5.7% and 4.6% of the candidate
peaks were significantly differentially bound for H3K4me3 and H3K27ac.
Thus derfinder is more conservative in which candidate peaks are identified
as differentially bound. The reciprocal comparison shows that 76.53% and
75.23% of derfinder’s dbPeaks overlap a DiffBind wide dbPeak for these his-
tone marks. These percents drop when comparing against DiffBind’s summit
dbPeaks.



















































































































































































































































































Table 3.3: Percent of 1 kb windows of the genome overlapping differentially
bound peaks. Percent of genome windows (1 kb each) that overlap at least one
dbPeak using derfinder or DiffBind. All candidates dbPeaks are shown first, then









H3K4me3 No 8.95 6.6 4.57
Yes 2.56 4.68 3.25
H3K27ac No 39.89 25.98 16.47
Yes 15.6 21.42 13
genome and calculated the percent of them that overlap a candidate dbPeak
as well as dbPeaks from all three methods as shown in Table 3.3. The results
show that derfinder considers candidate peaks in a larger percent of these 1
kb windows than DiffBind. When considering only the significant dbPeaks,
the percent of 1 kb windows overlapping derfinder dbPeaks is comparable
to the percent of windows with DiffBind’s summit dbPeaks and smaller
than DiffBind’s wide peaks. This is result is consistent with the widening
effect from merging peaks and the property of derfinder’s dbPeaks that all
base-pairs have differential binding signal.
3.4 Conclusions
Here we illustrated how derfinder [10] can be used to identify differentially
bound peaks (dbPeaks) using ChIP-seq data. This strategy for identifying
dbPeaks resolves the widening effect produced by merging peaks and the
limitations of focusing the analysis on peak summits. The dbPeaks identified
with derfinder have signal in all base-pairs which might not be the case for
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peaks derived from the currently available methods. This could lead to a
reduction in false positives in downstream analyses by avoiding regions of
the genome with low differential binding signal.
Using data from the EpiMap study [14] we showed how to identify dbPeaks
for more than 2 groups. We identified dbPeaks for histone marks H3K4me3
and H3K27ac based on 8 groups given by brain region, cell type and age at
time of death. These dbPeaks are mostly associated with cell type (NeuN
negative or positive) as it explains most of the variation in these peaks fol-
lowed by technical covariates. The overall residual variation is smaller than
in the Geuvadis RNA-seq experiment [18] due to how the dbPeaks are selected
versus using all genes. In a comparison with DiffBind [3] we showed that
derfinder is more conservative yet derfinder leads to similar percent of the
genome overlapping dbPeaks when compared against the merging strategy
that focuses on peak summits.
derfinder is flexible, annotation-agnostic and can be used for a wide vari-
ety of models, including time-course analyses and for more than 2 conditions.
derfinder can be used for both sharp and wide ChIP enrichment and defines
the regions based on the data at hand, but could be used for pre-defined
regions thus making it more versatile than most available methods for dif-
ferential binding analysis [6]. The core derfinder functionality is similar for
RNA-seq and ChIP-seq analyses, which could be an advantage for users ana-
lyzing both types of data sources. With the changes we made to derfinder
for ChIP-seq data we believe that it can be used for determining regions that
have differential signal between two or more conditions with genomic assays
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such as ATAC-seq, ChIP-exo, DNase-seq [22], among others. Note that no
input samples are needed for derfinder and that it can be used with bigWig
coverage files instead of BAM files.
3.5 Methods
3.5.1 Changes in derfinder for ChIP-seq data
In order for derfinder [10] to allow smoothing of the F-statistics, we changed
the findRegions() code. The new version of this function has additional
parameters to control how to perform the smoothing. By default, when
smoothing is used in derfinder, the smoothing is performed with the func-
tion locfitByCluster() from the bumphunter package [23]. We recommend
setting the minNum and minInSpan arguments to the read length and the bpSpan
argument to the expected peak size. Note that smoothing is disabled by de-
fault for backward compatibility with RNA-seq users.
3.5.2 Identification of dbPeaks from the EpiMap study with
derfinder
We downloaded the BAM files and sample phenotype data provided by
EpiMap [14]. We adjusted the coverage of each sample based on the total
number of mapped reads to libraries of 80 million base-pairs. For each histone
mark, we calculated F-statistics for the base-pairs that had at least one sample
with coverage greater or equal to 10 reads. The F-statistics are derived from an
intercept-only null model (3.1) for where yij corresponds to the log2 adjusted
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coverage for base-pair i of sample j with an offset factor of 32.
yij = αi + ϵij (3.1)
For the alternative model (3.2), we used a model with covariates for the
brain region (reference: ACC), cell type (reference: NeuN-), and age at time of
death.
yij = αi + βi1BrainRegionj + βi2CellTypej + βi3AgeAtDeathj + ϵij (3.2)
The F-statistics were smoothed with locfitByCluster() with arguments
minNum = 100, minInSpan = 100 and bpSpan = 300. The global F-statistic cutoff
used corresponds to a p-value of 0.01, candidate peaks were clustered using
maxClusterGap = 3000, and a total of 100 permutations were used to determine
family-wise error rate (FWER) adjusted p-values. A cutoff of 0.05 was used
to determine the differentially bound peaks. Results were first explored with
reports created with regionReport [24].
3.5.3 Analysis of dbPeaks identified with derfinder
We determined the overlap between significant dbPeaks for each histone mark
and Ensembl v75 [15] features using derfinder [10] as shown in Figure 3.4.
For each histone mark, we calculated the total coverage divided by the
read length for each significant dbPeak in each sample, resulting in a count
matrix (dbPeaks by samples). We log2-transformed this matrix (after adding
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an offset of 1) and selected only the dbPeaks with a FWER adjusted p-value
less than 0.05.
For each significant dbPeak we calculated the Bonferroni adjusted p-value
from adding brain region, cell type, or age at death (continuous) as a covariate
to an intercept-only model using the log2-transformed matrix for the corre-
sponding histone mark. The dbPeaks that associated (FWER < 0.05) with
these three covariates are shown in Figure 3.9 and were used in three separate
principal component analysis (PCA) as shown in Figure 3.5. Venn diagrams
were created by modifying code from limma [25].
Similarly, for each significant dbPeak we calculated the Bonferroni adjusted
p-value from adding one of the 12 other covariates shown in Figure 3.7 to
a model with the three main covariates. The resulting Bonferroni adjusted
p-values were used for clustering these 12 un-modeled covariates (Figure
3.11). We made coverage plots with derfinderPlot [13] and scatterplots with
ggplot2 [26] for the top 50 dbPeaks that are associated (FWER < 0.05) with
each of the 15 covariates. Some of them are highlighted in Figures 3.6 and 3.8.
We also performed a joint model with all 15 covariates using the log2-
transformed matrix for each significant dbPeak. We calculated the percent of
variance explained by each covariate and summarized the results in boxplots
as displayed in Figure 3.7.
3.5.4 Identification of dbPeaks with DiffBind
Peaks were called with MACS version 2.1.0 [1] for each sample using the cor-
responding input sample for the cell type analyzed. MACS was used with
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arguments --tsize = 100, -bw = 230. For each histone mark we merged the
peaks using DiffBind [3] with argument minOverlap = 2 and using the input
sample for the corresponding cell type. Differential binding between cell types
was determined using DESeq2 [7] as implemented in DiffBind. All consensus
peaks were retrieved using the argument th = 1 in the dba.report() function.
The resulting p-values were Bonferroni adjusted to control the FWER and a
cutoff of 0.05 was used to determine the differentially bound peaks. For the
DiffBind analysis that controlled the widening effect produced by merging
peaks, we used the argument summits = 250 in the function dba.count().
Genome tiles were created using using GenomicRanges [27] and this same
package was used to overlap derfinder and DiffBind results.
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Supplementary Methods and Results
3.9 Supplementary Results
Figure 3.9 shows whether the significant dbPeaks for each histone mark are
associated (FWER < 0.05) with brain region, cell type, or age at death. No-
tably, 89.2% and 94.5% of the dbPeaks are only associated with cell type for
H3K4me3 and H3K27ac.
H3K4me3 dbPeaks by main covariates











H3K27ac dbPeaks by main covariates












Figure 3.9: Differentially bound peaks for H3K4me3 and H3K27ac marks clas-
sified by the modeled covariates. (A) H3K4me3 and (B) H3K27ac dbPeaks. All
dbPeaks by covariate were used in Figure 3.5.
Figure 3.10 shows the decomposition of Figure 3.7 by Ensembl v75 features
shown on Figure 3.4. Interestingly, the dbPeaks that only overlap exonic and
intronic sequences (Figure 3.10, row 4) show an increase percent of variation
explained by the total mapped reads.
Figure 3.11 shows the relationship between the 12 un-modeled covariates
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Figure 3.10: Boxplots of percentage of variation explained by the 3 modeled covari-
ates, 12 other covariates, and residual variation by annotation. (A) H3K4me3 and
(B) H3K27ac dbPeaks overlapping Ensembl v75 strictly exonic (1), strictly intronic (2),
strictly intergenic (3), or exonic and intronic (4) features. The number of dbPeaks per
annotation feature are as given in Figure 3.4.
when controlling for brain region, cell type and age at death as clustered by
correlation between the -log10 Bonferroni adjusted p-values. For both marks,
height, weight, sex and BMI are clustered together as well as individual id
and library batch. The technical covariates are overall more closely related in
H3K27ac than in H3K4me3.
3.10 Supplementary Methods
The following paragraph summarizes the sample information from the EpiMap
study [14].

























































Un−modeled covariates clustered by −log10 p−value


























































Un−modeled covariates clustered by −log10 p−value(B) H3K27ac
Figure 3.11: Hierarchical clustering of the 12 un-modeled covariates. Clustering of
the -log10 Bonferroni adjusted p-values for the 12 un-modeled covariates compared
sequentially to a model with brain region, cell type and age shown for (A) H3K4me3
and (B) H3K27ac dbPeaks.
Health (NIMH) Human Brain Collection Core (HBCC)
http://www.nimh.nih.gov/labs-at-nimh/research-areas/research-support-services/
hbcc/human-brain-collection-core-hbcc.shtml. The human brain speci-
mens were collected in the Section on Neuropathology of the Clinical Brain
Disorders Branch at NIMH. Samples were dissected at the HBCC and shipped
to the Ichan School of Medicine - Mt Sinai for sample preparation. Samples
for the EpiMap study were dissected from a combination of right and left
hemisphere of fresh frozen coronal slabs cut at autopsy from the dorsolat-
eral prefrontal cortex (DLPFC) and the anterior cingulate cortex (ACC) from
Brodmann areas 9_10 and 24_32 respectively. For nuclei isolation the mouse
monoclonal antibody (clone A60) against neuronal marker NeuN (Millipore,
MAB377X) was used. Immuno-tagging with NeuN antibody conjugated to
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AlexaFluor 488 allowed for sorting of the nuclei into 2 fractions: NeuN+ (neu-
ronal) nuclei and NeuN- (non-neuronal) nuclei, using fluorescence-activated
cell sorting (FACS). Chromatin immunoprecipitation (ChIP) assays for hi-
stone marks H3K4me3 and H3K27ac were carried out using Native ChIP.
Micrococal Nuclease (MNase) (Sigma, N3755) treatment was used to digest
chromatin into mononucleosomes. The following antibodies were used for
chromatin pull-down: anti-H3K4me3 (Cell Signaling, Cat # 9751BC, lot 7) and
anti-H3K27ac (Active Motif, Cat# 39133, Lot # 01613007). Agilent Bioanalyzer,
Qubit concentration measurement and pQCR were used to quality control
the ChIP results. For sequencing, libraries were prepared in batches of 8
samples using KAPA Hyper Prep Kit and BIOO Scientific Adapters. After
each step, DNA was purified using AMPure beads (SPRI select) and final
library size selection (200-350 bp) was performed using Pippin Prep. Libraries
were barcoded based on the sequencing randomization scheme to allow for
multiplexing. The presence of the main library product (275 bp) and the ab-
sence of adapter dimer (125 bp) was confirmed using Agilent Bioanalyzer as a
quality control step. Libraries were sequenced with the goal that 40 millions of
uniquely mapped paired end reads for H3K4me3 and 80 millions of uniquely
mapped paired end reads for H3K27ac. Therefore, samples were sequenced
in batches of 8 (for H3K4me3) or 4 (for H3K27ac) per lane of the Illumina flow
cell. A pool of 4 or 8 barcoded libraries were layered on a random selection
of one of the eight lanes of the Illumina flow cell. One-hundred base pair
paired-end reads were obtained on a HiSeq 2500 in the Mount Sinai Genomics
core facility. Paired FASTQ files were aligned to the Human Genome (HG19)
with BWA mem (version 0.7.8). Picard (version 1.112) MarkDups was used
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to mark duplicates in the bam fies and multi-mapped reads and improperly
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4.1 Abstract
regionReport is an R package for generating detailed interactive reports from
region-level genomic analyses as well as feature-level RNA-seq results. The
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reports include quality-control checks, an overview of the results, an interac-
tive table of the genomic regions or features of interest and reproducibility
information. regionReport provides specialized reports for exploring DESeq2,
edgeR or derfinder differential expression analyses results. regionReport
is also flexible and can easily be expanded with report templates for other
analysis pipelines.
Keywords: Report, Interactive, Reproducibility, Genomics, Sequencing,
ChIP-seq, RNA-seq, Methylation, Software.
4.2 Introduction
Many analyses of genomic data result in regions along the genome that as-
sociate with a covariate of interest. These genomic regions can result from
identifying differentially bound peaks from ChIP-seq data [1], identifying
differentially methylated regions (DMRs) from DNA methylation data [2],
performing base-resolution differential expression analyses using RNA se-
quencing data [3, 4], among other analysis pipelines. The genomic regions
themselves are commonly stored in a GRanges object from GenomicRanges [5]
when working with R or the BED file format on the UCSC Genome Browser
[6]. Other information on these regions, for example summary statistics on
the magnitude of effects and statistical significance, also provide useful infor-
mation and can be stored as metadata in GRanges objects. The usage of R in
genomics is increasingly common due to the usefulness and popularity of the
Bioconductor project [7], and in the latest release (version 3.3) 300 unique pack-
ages use GenomicRanges for many workflows, demonstrating the widespread
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utility of identifying and summarizing characteristics of genomic regions.
Bioconductor is particularly strong for differential expression analyses,
with 206 packages using the Differential Expression BiocView. RNA-seq
data is commonly used to perform feature-level analyses at either the tran-
script, gene or exon levels with Bioconductor packages DESeq2 [8] and edgeR
[9, 10, 11], among others. The features can also be expressed regions identified
in an annotation-agnostic procedure by derfinder [3]. In an exploratory data
analysis of DESeq2 or edgeR results it is common to create a set of plots in order
to identify potentially problematic samples or features. For example, in such
a exploratory analysis it is common to use a dimension reduction technique
such as principal component analysis to determine if samples are clustering by
group or another variable of interest. This type of plot is useful for detecting
artifacts, such as mislabeling of samples.
Here we introduce regionReport which allows users to explore genomic
regions of interest, derfinder, DESeq2, and edgeR results through interactive
stand-alone HTML reports that can be shared with collaborators. These re-
ports are flexible enough to display plots and quality control checks within
a given experiment, but can easily be expanded to include custom visual-
izations or text describing the main conclusions of the exploratory analysis.
The resulting HTML report emphasizes reproducibility of analyses [12] by
including all the R code without obstructing the resulting plots and tables.
Alternatively, static PDF reports can be generated and easily shared among
collaborators. We envision regionReport will provide a useful tool for explor-
ing and sharing genomic region-based, DESeq2 and edgeR results from high
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chr  start end   strand  p-value
chr1 1000  2000  +       0.9
chr2 5000  8000  -       0.001
chr3 2468  2668  +       0.051
.    .     .     .       .
.    .     .     .       .
.    .     .     .       .
chrX 6000  6300  +       0.009




(A) default (B) custom
(C) derfinderReport
(D) DESeq2Report (E) edgeReport
Create HTML/PDF 
report
Figure 4.1: regionReport overview. Example region input, the appropriate
regionReport function to use, and menu of the resulting report for: (A) the gen-





The package includes R Markdown templates which are processed using
rmarkdown [13] and knitr [14] to produce HTML or PDF reports. HTML
reports can be styled using knitrBootstrap [15] or with rmarkdown templates
that include interactive features. The regionReport package generates a report
that includes a series of plots for checking the quality of the results and an





Figure 4.2: Interactively display the code for each table/figure in the report. (A) View
by default and (B) after clicking on the "code" toggle for a section in the report. The
HTML reports include a toggle to hide/show all the R code.
has a brief explanation, although actual interpretation of the results is dataset-
and workflow-dependent. To facilitate navigation a menu is included, which
is useful for users interested in a particular section of the report. Figure 4.1A
shows the menu of the general report for a set of regions with associated p-
values. The code for each plot or table is hidden by default and can be shown
by clicking on the "code" button as shown in Figure 4.2. Further customization
of the reports can be done by providing custom code, changing the default
plots, or by modifying the R Markdown templates included in regionReport.
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4.3.2 General region report
4.3.2.1 Quality checks
This section of the report includes a variety of quality control steps which help
the user determine whether the results are sensible. The quality control steps
explore:
• P-values, Q-values, and FWER adjusted p-values
• Region width
• Region area: sum of single-base level statistics (if available)
• Mean coverage or other score variables (if available)
A combination of density plots and numerical summaries are used in these
quality checks. If there are statistically significant regions, the distributions
are compared between all regions and the significant ones. For example, the
distribution region widths might have a high density of small values for the
global results, but shifted towards higher values for the subset of significant
regions as shown in Figure 4.3.
4.3.2.2 Genomic overview
The report includes plots to visualize the location of all the regions as well
as the significant ones. Differences between them can reveal location biases.
The nearest known annotation feature for each region is summarized and
visually inspected in the report. This type of plot can be useful to quickly



























Density of region lengths (significant only)
Figure 4.3: Distribution of region widths for all regions in the derfinder use case ex-
ample with the BrainSpan dataset. The top figure shows the region width distribution
for all regions while the bottom one shows it only for the significant regions. One line
is is shown per chromosome in each of the plots.
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Figure 4.4: Genomic overview of the annotation type for the significant regions in the
derfinder use case example with the Hippo dataset.
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annotation type. For example, Figure 4.4 shows the annotation information
for the significant regions with most regions contained inside genes, which is
expected with RNA-seq data.
4.3.2.3 Best regions
An interactive table with the top regions (500 by default) is included in this
section as shown in Figure 4.5A. This allows the user to sort the region in-
formation according to their preferred ranking option. For example, lowest
p-value, longest width, chromosome, nearest annotation feature, etc. The table
also allows the user to search and subset it interactively as shown in Figure
4.5B. A common use case is when the user wants to check if any of the regions
are near a known gene of their interest.
4.3.2.4 Reproducibility
At the end of the report, detailed information is provided on how the analysis
was performed. This includes the actual function call to generate the report,
the path where the report was generated, time spent, and the detailed R session
information including package versions of all the dependencies. An example
is shown in Figure 4.6 with the R package information truncated.
The R code for generating the plots and tables in the report is included in
the report itself, thus allowing users to manually reproduce any section of the





Figure 4.5: Interactive table with results for the top regions in the general use case
example using bumphunter results. The interactive table can (A) show all the top
regions or (B) a subset of the results by using the search box. The table can also be
sorted by each of the different columns.
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...
Figure 4.6: Reproducibility section for a report using DESeq2 results. The reproducibil-
ity information includes the actual function call used to generate the report, the path
where the report was generated, the time it took to create the report, details about the
R session information, and the pandoc version used for rendering the HTML report.
For reports based on DESeq2 results, the version used to perform the differential
expression analysis and cutoff used are also displayed. Note that DESeq2 version used
for the analysis and for the report might differ.
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4.3.2.5 Customization
regionReport allows users to customize the reports to their liking. This can
be done in different ways depending on the amount of customization the
user is looking for. Several plots are made with ggplot2 and the user might
want to change the default theme, for example to a black and white theme
as shown in the function call in Figure 4.6. Another user might be interested
in adding code that creates more plots than the ones included by default in
the report. For example, the user might be interested in adding a MA and a
PCA plot to the default report. This can be done via the customCode argument
which results in new sections added to the menu as shown in Figure 4.1B
compared to Figure 4.1A. Further customization can be achieved by modifying
the templates included in regionReport and using the template argument.
4.3.3 derfinder report
When exploring derfinder results from the single base-level approach, for
each of the best 100 (default) DERs a plot showing the coverage per sample is
included in the report. These plots allow the user to visualize the differences
identified by derfinder along known exons, introns and isoforms. The plots
are created using derfinderPlot [16].
Due to the intrinsic variability in RNA-seq coverage data or mapping
artifacts, in situations where there are two candidate DERs that are relatively
close there might be reasons to consider them a single candidate DER and
its important to visualize them. This tailored report groups candidate DERs





























Figure 4.7: Example region cluster plot for the derfinder use case example with the
BrainSpan dataset. Coverage curves are shown for each sample colored by their group
membership. Mean coverage curves by group, differentially expressed regions (DERs)
and known transcripts are shown in the remaining tracks.
the top 20 (default) clusters it plots tracks with the coverage by sample, the
mean coverage by group, the identified candidate DERs colored by whether
they are statistically significant, and known alternative transcripts as shown
in Figure 4.7. Figure 4.1C shows the main categories of the report generated
from a richer region dataset than in the general case.
4.3.4 DESeq2 and edgeR reports
Feature-level differential expression analyses result in a set of features (genes,
exons) with a p-value for each feature. To perform such analyses, some pheno-
type information about the samples is usually available. With this information,
you can explore the raw data to identify potentially problematic samples using
principal component analysis and sample distance plots. You can also explore
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Figure 4.8: Interactive table for top features from the DESeq2 use case example.
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the results and check the features marked as differentially expressed with MA
plots and a histogram of the p-values distribution. regionReport provides
a template that allows you to create all these plots easily for DESeq2 results
(Figure 4.1D). It has similar components to the region-level reports such as an
interactive table for the top features as shown in Figure 4.8, but also highlights
specific exploratory plots for this type of results. regionReport can also be
used for edgeR results (Figure 4.1E) resulting in very similar reports given the
internal implementation. The only difference is that reports for edgeR results
include sections for visualizing the biological coefficient of variation and the
multidimensional scaling plot of distances between feature expression profiles.
See the use cases for example reports from DESeq2 and edgeR results.
4.3.5 Operation
4.3.5.1 Installation
regionReport and required dependencies can be easily installed from Biocon-




To generate the report, the user first has to identify the regions of interest
according to their analysis workflow. For example, by performing bum-
phunting to identify DMRs with bumphunter. The report is then created using
renderReport() which is the main function in this package as shown in Figure
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4.1A,B.
For the derfinder use case, the derfinderReport() function creates the
recommended report that includes visualizations of the coverage information
for the best regions and clusters of regions. Similarly DESeq2Report() and
edgeReport() create reports for DESeq2 and edgeR results, respectively.
4.3.5.3 Output
A small example can be generated using:
example("renderReport", "regionReport", ask=FALSE)
The resulting HTML file will open in the users default browser when using
R in an interactive session. Note that alternative output formats such as PDF
files can also be generated, although they are not as dynamic and interactive
as the HTML format.
4.4 Use Cases
The supplementary website contains reports using DiffBind, bumphunter,
derfinder, DESeq2, and edgeR results. The derfinder use case is illustrated
with datasets described previously [3] which a moderately sized dataset (25
samples) and a large dataset with 484 samples. We encourage you to explore
the following example reports:




• customized general HTML report using DiffBind results with histograms
instead of density plots:
leekgroup.github.io/regionReportSupp/DiffBind-example/index.html,









• edgeR-robust HTML report:
leekgroup.github.io/regionReportSupp/edgeR-robust-example/index.
html,
• HTML report using derfinder results with the BrainSpan dataset (484
samples) and styled with knitrBootstrap:
leekgroup.github.io/regionReportSupp/brainspan/basicExploration.
html,
• HTML report using derfinder results with the Hippo dataset (25 sam-




regionReport creates interactive reports from a set of regions and can be used
in a wide range of genomic analyses. Reports generated with regionReport
can easily be extended to include further quality checks and interpretation
of the results specific to the dataset under study. These shareable documents
are very powerful when exploring different parameter values of an analysis
workflow or applying the same method to a wide variety of datasets. The
reports allow users to visually check the quality of the results, explore the
properties of the genomic regions under study, and inspect the best regions
and interactively explore them.
Furthermore, regionReport promotes reproducibility of data exploration
and analysis. Each report provides R code that can be used as the starting
point for other analyses within a dataset. regionReport provides a flexible




regionReport is freely available via Bioconductor at bioconductor.org/packages/
regionReport.
The supplementary website leekgroup.github.io/regionReportSupp/ hosts
the code and output for generating all the use cases described. Versions of all
software used are included in the reports.
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4.6.2 Latest source code
The latest source code is available at via GitHub at github.com/leekgroup/
regionReport. However, we highly recommend users to install regionReport
directly from Bioconductor at bioconductor.org/packages/regionReport.
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ReCount resource [5] which should be valuable to the research community.
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flexible and customizable, which we believe will make it more attractive to
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ITESM Campus Cuernavaca Cuernavaca, MX
High school, Grade 97.8/100 2002-2005
PhD thesis
Title: Annotation-Agnostic Differential Expression and Binding Analyses.
Advisors: Jeffrey T. Leek and Andrew E. Jaffe.
Description: The goal is to develop statistical methods and software that enable re-
searchers to differentiate the sources of variation observed in RNA-seq while minimizing
the dependance on known annotation. This will allow researchers to correct for technolog-
ical variation and study the biological variation driving their phenotype of interest. Then
apply these methods to further our understanding of neuropsychiatric disorders using the
Lieber Institute for Brain Development human brains collection (> 1000 samples).
Honors and awards
2011: Awarded CONACyT Mexico scholarship for PhD studies outside Mexico.
2009: Summa Cum Laude for bachelor in Genomic Sciences studies at LCG-UNAM.
2005: Best high school average (∼ 200 students): awarded ITESM system 90% scholarship
for college studies, declined to join LCG-UNAM.
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Experience
Industry. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Winter Genomics Cuernavaca, MX
Scientific executive 2009-2011
Responsible for recruiting and hiring new personnel, overseeing and supervising bioinformaticians,
training new employees, writing research reports and presenting them to colleagues, and organizing
all scientific projects.
 First scientific staff member at Winter Genomics;
 Projects completed:
- de novo genome assembly simulations,
- assembly and annotation of the phiVC8 bacteriophage genome,
- integrated analysis of more than 20 RNA-seq samples for determination of transcription
initiation in Escherichia coli reported in Gama-Castro et al., PMID 21051347,
- de novo assembly of four Escherichia coli strains and lead to Aguilar et al., PMID 22884033;
 Designed training material for new employees.
Research. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Enrique Morett lab IBT-UNAM, Cuernavaca, MX
Bioinformatician 2009–2011
Identified transcriptions start sites and transcription units in Escherichia coli and Geobacter
sulfurreducens with RNA-seq data. Developed the BacterialTranscription R package.
Guillermo Dávila lab CCG-UNAM, Cuernavaca, MX
Undergraduate research assistant 2007–2009
Determined bacteriophage ecological groups by developing a method based on codon distribution
of all phage sequenced genomes. Joint work with Sur Herrera Paredes.
Roberto Kolter lab Harvard, Boston, US
Undergraduate research assistant 2007
Supervisor: Elizabeth Shank. Carried out screenings to identify bacteria that activate the production
of exopolysaccharide through the activation of the gene tasA in Bacillus subtilis.
Publications
Peer-reviewed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1. Collado-Torres L, Jaffe AE and Leek JT. regionReport: Interactive reports for region-
level and feature-level genomic analyses [version2; referees: 2 approved, 1 approved
with reservations]. F1000Research 2016, 4:105. doi: 10.12688/f1000research.6379.2.
2. Jaffe AE, Shin J, Collado-Torres L, Leek JT, et al. Developmental regulation of human
cortex transcription and its clinical relevance at single base resolution. Nat. Neurosci.
2015. doi: 10.1038/nn.3898.
3. Shank EA, Klepac-Ceraj V, Collado-Torres L, Powers GE, Losick R, Kolter R. In-
terspecies interactions that result in Bacillus subtilis forming biofilms are mediated
mainly by members of its own genus. Proc. Natl. Acad. Sci. U.S.A. 2011
Nov;108(48):E1236–1243. doi: 10.1073/pnas.1103630108.
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4. Gama-Castro S, Salgado H, Peralta-Gil M, Santos-Zavaleta A, Muñiz-Rascado L, Solano-
Lira H, Jimenez-Jacinto V, Weiss V, García-Sotelo JS, López-Fuentes A, Porrón-Sotelo
L, Alquicira-Hernández S, Medina-Rivera A, Martínez-Flores I, Alquicira-Hernández
K, Martínez-Adame R, Bonavides-Martínez C, Miranda-Ríos J, Huerta AM, Mendoza-
Vargas A, Collado-Torres L, Taboada B, Vega-Alvarado L, Olvera M, Olvera L, Grande
R, Morett E, Collado-Vides J. RegulonDB version 7.0: transcriptional regulation of
Escherichia coli K-12 integrated within genetic sensory response units (Gensor Units).
Nucleic Acids Res. 2011 Jan;39(Database issue):D98–105. doi: 10.1093/nar/gkq1110.
Pre-prints (unpublished). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1. Collado-Torres L, Nellore A, Frazee AC, Wilks C, Love MI, Irizarry RA, Leek JT, Jaffe
AE. Flexible expressed region analysis for RNA-seq with derfinder. bioRxiv 015370
(2016). doi: 10.1101/015370.
2. Nellore A, Jaffe AE, Fortin JP, Alquicira-Hernández J, Collado-Torres L, Wang S,
Phillips RA, Karbhari N, Hansen KD, Langmead B, Leek JT. Human splicing diversity
across the Sequence Read Archive. bioRxiv 038224 (2016). doi: 10.1101/038224.
3. Nellore A, Collado-Torres L, Jaffe AE, Morton J, Pritt J, Alquicira-Hernández J, Leek
JT, Langmead B. Rail-RNA: Scalable analysis of RNA-seq splicing and coverage. bioRxiv
019067 (2015). doi: 10.1101/019067.
Pre-prints (published). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1. Collado-Torres L, Jaffe AE, Leek JT. regionReport: Interactive reports for region-based
analyses. bioRxiv 016659 (2015). doi: 10.1101/016659.
Books. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1. Frazee AC, Collado-Torres L, Jaffe AE, Langmead B, Leek JT. Measurement, Sum-
mary, and Methodological Variation in RNA-sequencing in Statistical Analysis of Next











Develop and maintain open-source biostatistical software.
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2015-2016: American Statistical Association
2014-2016: ENAR student member
2014: American Public Health Association
Presentations
Talks at conferences. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2016: Collado-Torres L, et al. Annotation-agnostic differential expression analysis,
ENAR, Austin – US. (slides)
2015: Collado-Torres L, Frazee AC, Love MI, Irizarry RA, Jaffe AE, Leek JT. Annotation-
agnostic differential expression analysis, Genomics and Bioinformatics Symposium, Center
for Computational Genomics, Hopkins, Baltimore – US.
2015: Jaffe AE, Shin J, Collado-Torres L, Leek JT, et al. Dissecting human brain
development at high resolution using RNA-seq, ENAR, Miami – US. (slides)
2014: Jaffe AE, Shin J, Collado-Torres L, Leek JT, et al. Developmental regulation
of human cortex transcription at base-pair resolution, is3b: 1st International Summer
Symposium on Systems Biology, INMEGEN, Mexico City – MX.
2014: Collado-Torres L, Frazee AC, Love MI, Irizarry RA, Jaffe AE, Leek JT. Fast
differential expression analysis annotation-agnostic across groups with biological replicates,
LCG 10 year anniversary, LCG-UNAM, Cuernavaca – MX.
2013: Collado-Torres L, Frazee AC, Irizarry RA, Jaffe AE, Leek JT. Differential expression
analysis of RNA-seq data at base-pair resolution in multiple biological replicates, useR2013,
Albacete – Spain.
2010: Collado-Torres L, Reyes-Quiroz A, Cuéllar-Partida G, Moreno-Mayar V, Vargas-
Chávez C, Collado-Vides J. BacterialTranscription: a R package to identify Transcription
Start Sites and Transcription Units, Bioconductor Developer Meeting, EMBL, Heidelberg
– Germany.
Posters. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2015: Collado-Torres L, Frazee AC, Love MI, Irizarry RA, Jaffe AE, Leek JT. Annotation-
agnostic RNA-seq differential expression analysis software, ASHG2015 and IDIES2015,
Baltimore – US.
2014: Collado-Torres L, Frazee AC, Love MI, Irizarry RA, Jaffe AE, Leek JT. Fast
annotation-agnostic differential expression analysis, ENAR and Delta Omega Poster
Competition (JHBSPH), Baltimore – US.
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2013: Collado-Torres L, Jaffe AE, Leek JT. Fast annotation-agnostic differential ex-
pression analysis, Genomics and Bioinformatics Symposium, Center for Computational
Genomics, Hopkins, Baltimore – US.
2010: Collado-Torres L, Reyes-Quiroz A, Cuéllar-Partida A, Moreno-Mayar V, Taboada
B, Vega-Alvarado L, Jiménez-Jacinto V, Mendoza-Vargas A, Grande R, Olvera L, Olvera
M, Vargas-Chávez C, Júarez K, Collado-Vides J, Morett E. Global Analysis of Transcription
Start Sites and Transcription Units in Bacterial Genomes, From Functional Genomics to
Systems Biology, EMBL, Heidelberg – Germany.
2010: Collado-Torres L, Reyes-Quiroz A, Cuéllar-Partida A, Moreno-Mayar V, Taboada
B, Vega-Alvarado L, Jiménez-Jacinto V, Mendoza-Vargas A, Grande R, Olvera L, Olvera
M, Vargas-Chávez C, Júarez K, Collado-Vides J, Morett E. Global Analysis of Transcription
Start Sites and Transcription Units in Bacterial Genomes, BioC2010, FHCRC, Seattle –
US.
Other talks. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2015: dbFinder, Joint Genomic Meeting, JHBSPH, Baltimore – US.
2015: Easy parallel computing with BiocParallel and HTML reports with knitrBootstrap,
Biostatistics Computing Club, JHBSPH, Baltimore – US.
2015: Does mapping simulated RNA-seq reads provide information?, Joint Genomic
Meeting, JHBSPH, Baltimore – US.
2014: Git for research, Biostatistics Computing Club, JHBSPH, Baltimore – US.
2013: Introduction to ggbio, Genomics for Students, JHBSPH, Baltimore – US.
2013: Introduction to knitr, Biostatistics Computing Club, JHBSPH, Baltimore – US.
2013: Introduction to High-Throughput Sequencing and RNA-seq, Genomics for Students,
JHBSPH, Baltimore – US.
2012: DEXSeq paper discussion, Genomics for Students, JHBSPH, Baltimore – US.
2012: Introduction to R and Biostatistics, LCG-UNAM via Skype.
2012: Introducing Git while making your academic webpage, Biostatistics Computing
Club, JHBSPH, Baltimore – US.
2011: Introducing Biostatistics to first year LCG students, LCG-UNAM via Skype.
2010: Introduction to using Bioconductor for High Throughput Sequencing Analysis,
National Bioinformatics Week, CCG-UNAM, Cuernavaca – MX.
2009: Bacteriophages: analyzing their diversity, LCG third generation symposium, CCG-
UNAM, Cuernavaca – MX.
Courses and Meetings Attendance
2016: ENAR, Austin – US.
2015: ENAR, Miami – US.
2014: is3b, INMEGEN, Mexico City – MX.
2014: BioC2014, Harvard, Boston – US.
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2014: IDIES2014, Johns Hopkins University, Baltimore – US.
2014: ENAR, Baltimore – US.
2014: Delta Omega Poster Competition, Johns Hopkins University, Baltimore – US.
2014: LCG 10 year anniversary, LCG-UNAM, Cuernavaca – MX.
2013: Genomics and Bioinformatics Symposium, Johns Hopkins University, Baltimore –
US.
2013: useR2013, Albacete – Spain.
2011: BioC2011, FHCRC, Seattle – US.
2010: From Functional Genomics to Systems Biology, EMBL, Heidelberg – Germany.
2010: BioC2010, FHCRC, Seattle – US.
2009: BioC2009, FHCRC, Seattle – US.
2009: Course on Oral Communication taught by the master Rafael Popoca, CCG-UNAM,
Cuernavaca – MX.
2008: BioC2008, FHCRC, Seattle – US.
2008: A Short R/Bioconductor Course by James Bullard from UC Berkeley, LCG-UNAM,
Cuernavaca – MX.
2007: Boston Bacterial Meeting, Boston – US.
2007: Retreat of the Department of Microbiology and Molecular Genetics - Harvard,
Boston – US.
2006: Winter School in Genomics, CCG-UNAM, Cuernavaca – MX.
2005: HUGO 2005, Kyoto – Japan.
Software
Bioconductor – main author. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2014: derfinder: Annotation-agnostic differential expression analysis of RNA-seq data at
base-pair resolution via the DER Finder approach – 5745 downloads.
2014: derfinderPlot: plotting functions for derfinder results – 4477 downloads.
2014: regionReport: Generate HTML or PDF reports for a set of genomic regions or
DESeq2/edgeR results – 4254 downloads.
2014: derfinderHelper: helper functions for derfinder package – 5168 downloads.
2014: derfinderData: data for derfinder examples – 1112 downloads.
Bioconductor – contributor role. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2015: bumphunter
2014: ballgown
Other R packages. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2016: recount: Explore and download data from the recount project.
2014: enrichedRanges: identify enrichment between two sets of genomic ranges.
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2014: dots: simplify function calls.
2013: fitbitR: visualize your FitBit data.
2011: BacterialTranscription: identify TSSs and TUs from RNA-seq data.
shiny applications. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2014–2016: MPH capstone TA office hours sign up
2014: Simple mortgage calculator
Miscellaneous. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2016: Updated the JHU thesis template available at GitHub and Overleaf
Computer skills
all-purpose: R Ranked 152/5661 in the US and 418/53325 worldwide by GitHub Awards as of






cluster queue: Sun Grid Engine
Teaching Experience
Instructor. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 PDCB-UNAM, Cuernavaca, MX
2011: Invited instructor for the course Introduction to R and Biostatistics (website)
∼ 10 enrollment.
2010: Analysis of High-Throughput Sequencing data with Bioconductor for Biomedical
Sciences PhD Program students (website) ∼ 10 enrollment.
 CCG-UNAM, Cuernavaca, MX
2010: Introduction to Using Bioconductor for High-Throughput Sequencing Analysis
practice lab at the National Bioinformatics Week ∼ 40 enrollment.
 IBT-UNAM, Cuernavaca, MX
2010: Introduction to R and plotting with R course for Morett’s lab ∼ 10 enrollment.
2010: Organized and gave a lecture for the course on Statistical Methods and Analysis
of Genomic Data (website) ∼ 20 enrollment.
2009: Organized the course Introduction to Bioinformatics for Morett’s lab and served
as instructor for the Introduction to R and plotting with R module (website) ∼ 10
enrollment.
 LCG-UNAM, Cuernavaca, MX
2009: Seminar III: R/Bioconductor. In-depth Bioconductor course (website) ∼ 30
enrollment.
124
Guest lecturer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 JHBSPH, Baltimore, US
2015: Introduction to R for Public Health Researchers: Reproducible research module
∼ 20 enrollment.
 LCG-UNAM, Cuernavaca, MX
2012: Introduction to R and Biostatistics lecture for Seminar 1: Introduction to
Bioinformatics course ∼ 30 enrollment.
2011: Introduction to R and Biostatistics lecture for Seminar 1: Introduction to
Bioinformatics course ∼ 30 enrollment.
Lead teaching assistant. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 JHBSPH, Baltimore, US
2015–2016: Statistical Methods in Public Health II ∼ 550 enrollment.
2014–2015: Statistical Methods in Public Health I and II ∼ 550 enrollment.
Teaching assistant. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 JHBSPH, Baltimore, US
2014–2016: MPH capstone project: 30 min one-on-one consulting sessions (biostatis-
tics, Stata coding) ∼ 500 enrollment. Develop and maintain the MPHcapstoneTA shiny
application.
2015–2016: Statistical Methods in Public Health I ∼ 550 enrollment.
2015: Introduction to R for Public Health Researchers ∼ 20 enrollment.
2013–2014: Statistical Methods in Public Health I and II ∼ 550 enrollment.
2012–2013: Statistical Methods in Public Health I, II, III, and IV ∼ 550 enrollment.
 LCG-UNAM, Cuernavaca, MX
2009: Principles of Statistics. Basic R (website) ∼ 30 enrollment.
2008: Bioinformatics and Statistics I. R and Bioconductor overview (website) ∼ 40
enrollment.
Mentoring
2015: Mentored Alquicira-Hernández J, LCG-UNAM student visiting Jeff Leek’s group.
2009–2011: Advised and trained 13 LCG-UNAM students and alumni while working at
Winter Genomics: Riveros-McKay F, Vargas-Chávez C, Dulanto-Acevedo V, Romero-
Martínez S, Samaniego-Castruita J, Zepeda-Mendoza L, Vargas-Velázquez A, Noé-González
M, Soto Jiménez LM, López Moyado I, Medina-Abarca H., Izquierdo-Rangel E, and
Berrocal-Quezada NA.
2009: Trained 3 LCG-UNAM students to take over the R/Bioconductor course: Reyes-
Quiroz A, Moreno-Mayar V, and Reyes-López J.
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Other
2016: Student representative for the Centennial celebration of the Department of Bio-
statistics.
2012–2016: Organized Cultural Mixer events for the Department of Biostatistics with
Amanda Mejia for raising cultural awareness.
2012–2014: Organized the Genomics for Students group (website)
2009–2011: Organized a Genomics Journal Club at IBT-UNAM.
2008–2009: Elected class representative for the LCG Academic Committee.
2008–2009: Class representative for Administration Unit for Technology Information
committee.
2008: Helped start the National Node of Bioinformatics online forum.
Languages
Native: Spanish
Bilingual: English
Basic: French
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